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ABSTRACT 
 
Mechanisms of environmental carcinogenesis and metal-induced cellular signaling. 
 
 
Jacquelyn Jo Bower 
 
 
Low dose chronic exposure to environmental carcinogens is a major cause of 
human cancers.  More than 375 known or suspected environmental carcinogens have 
been identified, many of which are transition metals or metal containing compounds 
(IARC, updated to 2004, http://www-cie.iarc.fr/monoeval/crthall.html).  Although much 
research has focused on the ability of these metals to induce reactive oxygen species 
formation (ROS), DNA damage, and apoptosis, less effort has been put forth to examine 
the cellular signaling mechanisms responsible for these effects.  Our experimental 
research has focused on the signaling pathways induced in response to arsenic exposure.  
Arsenic is a highly interesting transition metal due to its widespread exposure and 
paradoxic ability to induce carcinogenesis as well as apoptosis.  Here, we highlight the 
importance of the human genome project in advancing the knowledge of the molecular 
mechanisms of metal-induced toxicology/carcinogenesis.  In addition, we review the 
latest research in the field of metal-induced carcinogenesis.  Finally, we describe a 
mechanism for the induction of the growth-arrest and DNA damage inducible protein 45 
alpha (GADD45α) involving arsenic-induced ROS formation in the non-tumorigenic 
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SECTION I:  OVERVIEW 
 1
Arsenic 
Arsenic is a ubiquitous environmental contaminant found in food, water, cigarette 
smoke, soil, pesticides, and wood preservatives; thus, exposure can occur through dermal 
contact, inhalation, ingestion, and occupational routes (1-8).    A multitude of adverse 
health effects, including hyperkeratosis, hyperpigmentation, diabetes mellitus, 
cardiovascular disease, reproductive defects, and cancers of the liver, bladder, skin, lung, 
kidney, and prostate, have been associated with arsenic exposure (9-17).  The most 
common route of exposure is the ingestion of arsenic contaminated drinking water, which 
has been documented in Latin America, South Asia, Taiwan, the United States, and Japan 
at concentrations as high as 1.5-3.4 mg/L (18-25).  These figures exceed the World 
Health Organization’s maximum contaminant level of 10 ug/L by ten-fold or more.  In 
the U.S. alone, an estimated 56 million Americans are exposed to concentrations of 
arsenic known to cause cancer (18,19,23-25).   
Arsenic was first suggested to act as a human carcinogen by Hutchinson in the 
year 1887 when he noticed an abnormal number of skin cancers occurring in patients who 
were being treated with arsenicals (19).  Since then, epidemiological studies have shown 
that arsenic exposure is associated with cancers of the skin, lung, liver, bladder, and 
prostate (9-12).  In 1980, Rossman et al showed that inorganic arsenic was poorly 
mutagenic and genotoxic in both E. coli and CHO cells (26).  Although arsenic induces 
DNA adduct formation, DNA-protein crosslinks, and ROS formation in vitro, attempts to 
examine the in vivo carcinogenic effects of arsenic in rodent models have largely failed in 
the absence of another carcinogenic agent (27-29).   
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 Because of arsenic’s poor mutagenicity, the current theory is that its carcinogenic 
effects are mediated by epigenetic mechanisms.  This hypothesis is supported by the 
studies of Chen et al, in which overexpression of the oncogene c-myc and DNA 
hypomethylation of the promoter region of the estrogen receptor alpha gene have been 
observed in liver tumors of adult rats exposed to arsenic in utero (30,31).  Additional 
supporting evidence includes the identification of the Erk MAPK as an essential 
component of the signal transduction pathways responsible for arsenic-induced 
transformation of JB6 murine fibroblast cells in vitro (32).  Other studies have suggested 
that arsenic may prevent signaling events leading to cellular differentiation. For example, 
inorganic arsenic has also been shown to suppress involucrin expression, a marker of 
keratinocyte differentiation (33). 
 Although the previously described studies strongly suggest that gene expression 
and protein signaling events activated and suppressed during arsenic exposure play a 
central role in arsenic-induced tumorigenesis in vitro, knowledge of the signaling 
mechanisms responsible for transformation in a human model system remain virtually 
non-existent.  Several colleagues have examined the transcriptional profiles of cell lines 
and tissues that have been exposed to arsenic.  Examples include Liu’s group (34), who 
showed that hepatocellular carcinoma induced by arsenic exposure in utero upregulated 
the expression of 56 genes and downregulated the expression of 26 genes when compared 
to non-tumor liver samples from CH3 mice.  Moreover, gene expression changes in a 
BEAS-2B cell line differed between low (5 μM) and high (50 μM) doses of arsenic.  In 
the high dose samples, general stress response genes were induced, whereas more subtle 
changes were observed at a lower dose of arsenic (35).   
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To date, only three groups have examined the effects of arsenic in mammalian 
models on a proteomic scale (36-38).    Yet, both Lau’s and He’s groups used a rat lung 
epithelial cell line in which arsenic-induced transformation was not observed (37).  In 
addition, He’s group used the known carcinogen benzo-a-pyrene in conjunction with 
arsenic treatment (36). Furthermore, Wang’s group chose to study only the nuclear matrix 
fraction of the K562 chronic myelogenous leukemic cell line in which arsenic is known 
to induce apoptosis, not transformation (38).  In spite of the valuable information 
provided by these studies, an understanding of the signaling pathways responsible for 
arsenic-induced carcinogenesis is still in its infancy. 
 
GADD45α 
One epigenetic mechanism by which arsenic may induce carcinogenesis is 
through the dysregulation of the cell cycle.  Previous research from our laboratory has 
suggested that arsenic can increase the number of BEAS-2B cells found in the G2/M 
phase fraction in a dose-dependent manner (39).  The GADD45α protein is a major 
player in the G2/M phase checkpoint, and a transcriptional profile analysis of the BEAS-
2B cells showed that the gadd45a gene is upregulated in response to both low and high 
dose exposure to arsenic (35).  We therefore hypothesized that GADD45α may be 
involved in arsenic’s ability to induce G2/M phase arrest.   
The involvement of GADD45α in the G2/M phase checkpoint is thought to occur 
through its interaction with the cyclin dependent kinase cdc2 (also known as cdk1).  
GADD45α is thought to bind to cdc2 and sequester it in the cytoplasm preventing cdc2 
from associating with its cyclin counterpart, cyclin B1 (40).   Recombinant GADD45α 
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(rGADD45α) protein expression has been shown to prevent cdc2 from 
immunoprecipitating with cyclin B1, thus specifically inhibiting cyclin B1/cdc2-
dependent phosphorylation of its target protein histone H1 in vitro (40).   
Additional functions of GADD45α have also been proposed.   For example, 
Smith et al have shown that GADD45α and the proliferating cell nuclear antigen (PCNA) 
coimmunoprecipitate in ML-1 human myeloid leukemia cells containing a functional p53 
gene upon exposure to ionizing radiation (IR) (41).  PCNA is a sliding clamp ring protein 
that functions in DNA synthesis and recruits DNA repair proteins to the site of DNA 
damage (42).  Furthermore, rGADD45α addition has also been shown to stimulate 
nucleotide excision repair (NER) in both ML-1 and RKO cells (41).  Taken together, 
these results suggest that PCNA may recruit GADD45α to the site of DNA damage 
during cellular proliferation, implying a role for GADD45α as a link between the DNA 
damage sensing machinery and DNA damage repair. 
GADD45α has also been shown to play a role in G1/S phase arrest.  Exposure of 
mouse embryo fibroblasts to IR can induce a p53-dependent G1/S phase arrest (43).   
GADD45α mRNA was increased after IR in the wild-type p53 ML-1, RKO, WI38, 344, 
U2-OS cell lines, but not in p53-deficient cell lines (43).  Furthermore, p53 deficiency 
prevented GADD45α mRNA induction and led to a loss of G1 arrest after IR (43). An 
alternative mechanism of GADD45α action at the G1/S phase checkpoint suggests that it 
can prevent DNA synthesis from occurring, since a Balb/c-3T3 fibroblast GADD45α-
IPTG-inducible cell line can inhibit entry into S phase when IPTG is present (44). 
Another function of the GADD45α protein is to allow for topoisomerase I 
relaxing and cleavage activity (45). Addition of GADD45α and core histones can relax 
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supercoiled DNA (45). GADD45α can directly bind histones H1, H2A, H2B, H3, and 
H4, and subsequently interfere with their ability to interact with DNA (45).  Furthermore, 
DNAse I sensitivity increased when GADD45α was added in the presence of 
hyperacetylated nucleosomes (45). GADD45α can bind only hyperacetylated 
nucleosomes (not underacetylated) and can also bind UV-damaged DNA 
mononucleosomes and free DNA damaged by UV (45).   The region of the protein 
responsible for these interactions is contained in amino acids 71-124 (45).  Interestingly, 
this is the same region of the GADD45α protein responsible for preventing cdc2/cyclin 
B1 kinase activity and phosphorylation of histone H1. 
 
Regulation of GADD45α 
gadd45a is an inducible gene that was isolated as a novel mRNA increased after 
DNA damage (46).  It is induced by many different types of cellular stress including 
methylmethane sulfonate (MMS) treatment, medium starvation, ionizing radiation (IR), 
ultraviolet radiation (UV), and sodium arsenite (47).  Depending on which type of 
stressor is present in the system, the mechanisms of gadd45a induction differ. The most 
studied mechanism is the p53-dependent mechanism; however, a p53-independent 
mechanism also exists.    
  In some cases, the first step required for the transcription of inducible genes is the 
remodeling of nucleosomes.  This allows the transcription factor to bind to the inducible 
gene and increase gene expression.  In other cases, the nucleosomes have already been 
arranged around the transcription factor binding sites, allowing for quick binding of the 
selected transcription factor at any time.  The gadd45a gene is thought to be one of these 
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so-called preset genes, in which the nucleosomes are arranged such that the promoter 
region and the 3rd intron are poised for easy access to transcription factors, since these 
regions are hypersensitive to DNase cleavage (48).  Therefore, most studies of gadd45a 
transcriptional regulation have focused on the promoter and 3rd intron regions. 
 
p53 
  The p53-dependent mechanism of gadd45a induction is usually seen in response 
to IR exposure.  Graunke et al, have shown that IR treatment causes a 15-fold induction 
of gadd45a mRNA as measured by northern blotting in the absence of de novo protein 
synthesis (48).  In addition, Zhan et al have shown that the p53-dependent induction of 
gadd45a occurs via p53 binding to its consensus sequence in the 3rd intron of the 
gadd45a gene and subsequently interacting with the WT1 transcription factor (49).  
However, this response seems to be strictly employed only with exposure to IR. 
 
Oct-1 
Oct-1 is a ubiquitously expressed cis-regulatory transcription factor of the POU 
(pit-oct-unc) family.  It has been shown to regulate the transcription of many genes, 
including histone H2B, the small nuclear RNA gene, immunoglobulin genes in B cells, 
the von Willebrand factor, TIF2, GnRH, and the vascular cell adhesion molecule 
(VCAM) gene (50,51).  The Oct-1 transcription factor has also been shown to bind the 
promoter region of the gadd45a gene between -101 to -82 bp relative to the 
transcriptional start site (TSS) in a p53-independent manner following MMS treatment 
and UV irradiation (50-53).   
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Takahashi and colleagues have suggested that a cofactor is needed in order for 
Oct-1 to induce gadd45a transcription in response to UV treatment (50).  Jin et al have 
suggested that this cofactor may be the ubiquitous NF-YA transcription factor which 
binds to a CAAT-box motif located in the same region of the gadd45a promoter as the 
Oct-1 binding motif.  Both Jin and Zhao found that Oct-1 is induced in response to MMS 
treatment, which contradicts Takahashi’s results suggesting that Oct-1 abundance was not 
increased in response to UV stimulus (50-52).  Jin also suggests that Oct-1 protein 
induction is mediated through a post-transcriptional mechanism (PTM), whereas 
Takahashi claims that the Oct-1 protein is not modified (50,51).  These differences could 
be due to differences in the cell lines examined or the stimulus used for the induction of 
gadd45a.  Both Takahashi’s and Jin’s work is supported by that of Graunke et al, in 
which LMPCR was used to identify potential protein binding interactions, one of which 
was the Oct-1 transcription factor (48). 
 
ZBRK1 
  ZBRK1 is a zinc finger protein that is thought to repress gadd45a transcription 
by binding to the 3rd intron in a BRCA1-dependent manner (54).  BRCA1 itself cannot 
bind directly to a regulatory DNA sequence; it must associate with a transcription factor 
that is capable of binding to a specific DNA sequence.  There may be additional ZBRK1 
binding sites in the gadd45a promoter region (54).  Many other genes besides gadd45a 
contain putative ZBRK1 binding sequences, including GADD153, Ki-67, Bax, p21, 
EGR1, amphiregulin, prothymosin, TIMP-1, TIMP-2, and Topo IIa, suggesting that 
ZBRK1 may be involved in the cellular response to DNA damage (55).  Yun et al have 
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recently shown that upon UV and MMS exposure, ZBRK1 is rapidly degraded (within 30 
minutes) by the ubiquitin proteasome pathway, which subsequently results in an increase 
in GADD45α protein expression (54).  One possibility is that stress activation of BRCA1 
could promote the degradation of ZBRK1 through its E3 ubiquitin ligase activity, 
relieving gadd45a gene repression. 
 
c-Myc 
 c-Myc is a well-known oncogene that increases its expression in response to 
mitogens.  Its de-regulation prevents cells from exiting the cell cycle and from 
responding to growth-arrest signals.  c-Myc has been shown to regulate many cell cycle 
control genes including Cdc25a, eIF-4E, C/EBPα, cyclin D1, GADD153, and most 
recently GADD45α (56).  Marhin et al, report that c-Myc activation represses gadd45a 
transcription and that this process requires de novo protein synthesis (56).  Interestingly, 
amino acids 106-143 of c-Myc are required for suppression of gadd45a transcription, the 
same region required for cell cycle progression and c-Myc-induced cellular 
transformation (56).  Despite the absence of a canonical c-Myc binding site in the 
gadd45a gene, c-Myc represses its transcription possibly by inhibiting CAAT-binding 
transcription factors such as the CTF/NF1 or C/EBP family of transcription factors (52, 
56).  Graunke’s LMPCR results in ML-1 cells support Marhin’s results, suggesting that 
C/EBP binds to the gadd45a promoter region (48).   
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NF-κB
 UV treatment has also been shown to activate NF-κB, a known inhibitor of JNK 
expression.  NF-κB is thought to cause an inflammatory response and has been shown to 
be overexpressed in many cancer cell systems.  Zerbini et al have recently reported that 
NF-κB can repress gadd45a transcription in an indirect manner by activating c-Myc (57).  
After inhibiting NF-κB activation, an increase of approximately 3-fold in GADD45α and 
γ mRNA was observed (57).  The inhibition of NF-κB is thought to prevent cell 
proliferation and increase apoptosis, both of which have been suggested to be functional 
roles for the GADD45 family of proteins. 
 
FOXO3a
 FOXO3a is a member of the forkhead transcription factor family, and its sequence 
is similar to that of the DAF-16 gene in C. elegans, which is required for SOD and 
catalase transcriptional upregulation.  DAF-16 has been shown to be involved in stress 
resistance and an increased life span, whereas FOXO3a overexpression has been shown 
to result in G1 arrest (58).  FOXO3a is a downstream target of the PI3K and PKB/Akt 
pathway, which promotes cell survival.  PKB/Akt phosphorylates and inhibits FOXO 
transcription factors, sequestering the transcription factor in the cytoplasm.  Tran et al, 
have shown that inducible expression of an Estrogen Receptor-FOXO3a fusion protein 
with 4-hydroxytamoxifin can induce gadd45a promoter luciferase activity in a Rat-1 cell 
line (58).  Tran and colleagues identified the positions of the forkhead response elements 
(FHREs) in the gadd45a promoter region at -505, -377, and -803, relative to the TSS.   
 10
In cells passing through the G2 phase, FOXO3a was localized to the nucleus.  In 
addition, constitutive expression of FOXO3a led to a G2/M phase delay as did treatment 
with a PI3K inhibitor, LY294002.  Furthermore, overexpression of FOXO3a managed to 
repair a UV damaged CMV-luciferase construct in RKO and MEF cells.  Tran et al also 
showed that FOXO3a could bind directly to the FHRE2 and FHRE3 elements in the 
gadd45a promoter region (58).  All of the FOXO3a effects on G2 arrest and the UV 
damaged CMV luciferase construct were diminished in a GADD45α -/- fibroblast cell 
line, suggesting that the effects of GADD45α are at least in part mediated through a 
transcriptional increase of GADD45α protein by FOXO3a (58). 
 
Post-Transcriptional Regulation 
In addition to transcriptional upregulation, GADD45α has also been shown to be 
post-transcriptionally regulated.  Rishi et al observed a four-fold increase in the amount 
of GADD45α mRNA stability in a human breast carcinoma cell line after treatment with 
the synthetic retinoid CD437 which has been shown to cause G0/G1 arrest and apoptosis 
(59). Rishi’s group further established that GADD45α mRNA stability is dependent upon 
45 base pairs of the 5’ untranslated region (UTR) of the GADD45α mRNA (59).  Rishi’s 




Because GADD45α is a stress-inducible protein that is responsive to a multitude 
of DNA damaging agents each with their own mechanism of action, it is reasonable to 
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suggest that its induction may be related to the production of ROS.  UV-irradiation, IR, 
and sodium arsenite have all been shown to produce ROS in cellular systems and also 
induce GADD45α expression (60).  We have therefore hypothesized that ROS can act as 
second messengers to induce the GADD45α protein and possibly mediate the effects of 
ROS on the cell cycle, apoptosis, and DNA damage repair.  The experimental research 
presented in this manuscript suggests that arsenite can transcriptionally induce 
GADD45α expression via the formation of H2O2 through a Fenton-like reaction 
mechanism.   
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Environmental Health Research in the Post-Genome Era:  New 




The human genome sequence provides researchers with a genetic framework to 
eventually understand the relationship between gene-environment interactions.  This 
wealth of information has led to the birth of several related areas of research including 
proteomics, functional genomics, pharmacogenomics, and toxicogenomics. Developing 
techniques such as DNA/protein microarrays, siRNA applications, 2-D gel 
electorphoresis and mass spectrometry in conjunction with advanced analytical software 
and the availability of internet databases offers a powerful set of tools to investigate an 
individual’s response to specific stimuli.  Here, we summarize these emerging scientific 
fields and techniques focusing specifically on their applications to the complexities of 




Environmental exposure, genetic susceptibility, and age undergo a set of complex 
interactions to induce human disease (Rall and Groopman, 1994; National Institute for 
Envrionmental Health Sciences (NIEHS): Intro to NIEHS, 2002).  The prevention and 
treatment of human disease relies on the ability to understand the exact cause and effect 
relationship among these factors and to identify which events are involved in the onset 
and progression of disease.  The recently completed draft sequence of the human genome 
could create seemingly endless opportunities for the delineation of gene-environment 
interactions.  By determining the relationship between environmental exposure and 
genetic susceptibility, the environmental health research community has the ability to 
unlock these mysteries.   
Since the inception of the Human Genome Project in 1990 (Fink, 1990), new 
avenues of research such as proteomics, functional genomics, and toxicogenomics have 
rapidly emerged. In February 2001, two separate drafts of the human genome sequence 
were published (Venter et al, 2001; International Human Genome Sequencing 
Consortium (IHGSC), 2001).   In April of 2003, the IHGSC finally announced the 
completion of the human genome sequence (Pennisi, 2003; National Human Genome 
Research Institute, 2003).  New techniques including DNA microarrays, small-interfering 
RNA (siRNA), and protein microarrays have already yielded promising results towards 
improving health and treating human disease (Heller et al, 1997; Novina et al, 2002; 
Belov et al, 2001).  By integrating information gathered from the human genome 
sequence, epidemiological surveys, and gene-association/susceptibility studies, it may be 
possible to determine how genes and environmental stressors are interrelated.  These 
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studies could lead to the generation of novel strategies for treating diseases with 
underlying genetic components.  Here, we discuss advances in the new fields and 
techniques that have emerged with the promise of a complete human genome sequence 
and their applications to gene-environment interaction studies. 
 
Environmental Exposure and Genetic Susceptibility 
Humans are continually exposed to hazardous agents in the environment through 
air, water, soil, diet, and the workplace (Churg et al, 2003; Tsai et al, 1999; Malaka et al, 
1990; Gambelunghe et al, 2003).  Previously, there have been many studies focusing on 
the acute effects of high-dose exposure to environmental agents.  However, much less 
data is available concerning the effects of low-dose chronic exposure to many 
environmental agents.  Chronic exposure to an environmental toxin, even at a low dose, 
can be just as harmful to an organism as an acute exposure.  For example, toxic agents 
such as cadmium have been shown to accumulate in tissues over time and lead to 
multiple adverse effects in exposed individuals (Hunder et al, 2001; Staessen et al, 1999).  
However, not all individuals who are exposed to an environmental agent will manifest 
disease, suggesting that many of the effects resulting from a low-dose chronic exposure 
to an agent may have a complex genetic and/or non-genetic basis.  Further complications 
of exposure assessment include variations in the route of exposure, concentrations of the 
toxic substance, and the number and length of exposures, rendering each individual’s 
exposure pattern unique.  
It has long been thought that the genetic makeup of each individual plays a key 
role in the cellular response to a toxic agent (International SNP Map Working Group, 
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2001).  There are several types of genetic variations that have been observed in humans, 
including the loss of one or both alleles for a specific gene, alternative splicing variants, 
and the presence of single nucleotide polymorphisms (SNPs), which are the most 
common type of genetic variation.  An example of the effect of genetic variation on a 
cellular process is illustrated by the different expression levels of several cellular 
antioxidant enzymes in Type 1 Diabetes patients (Hodgkinson et al, 2003).    When cells 
and tissues are exposed to a toxic agent such as Cr(VI), the antioxidant enzymes are 
triggered as a defense system to repair the cellular damage.  If, however, a large amount 
of cellular damage is induced by the Cr(VI) exposure, then the balance between the 
antioxidant defense mechanisms and the oxidants may be upset.  The oxidant-induced 
damage may be permanent and lead to apoptotic or necrotic cell death (Ye et al, 1999).   
Environmental exposure to agents such as chromium, arsenic, and nickel has been shown 
to affect several cellular signaling pathways, suggesting that an individual’s genetic 
variation in any gene involved in these pathways could potentially affect susceptibility 
(Barchowsky and O’Hara, 2003; O’Hara et al, 2003; reviewed in Chen and Shi, 2001).  
As a result, a Type I Diabetes patient that is subsequently exposed to an environmental 
insult may have a less effective antioxidant defense system than that of a non-diabetic.   
There are several ways a toxic agent can elicit a cellular response.  For example, 
an inappropriate activation or modification of proteins involved in the cell survival/DNA 
repair/apoptotic signaling pathways can lead to increased non-specific tyrosine 
phosphorylation (Qian et al, 2001).  Toxic agents, such as nickel, arsenic, and cadmium 
may also inhibit enzymes responsible for protection from carcinogenic agents (Poirier 
and Vlasova, 2002).  In addition, toxic agents have also been shown to induce mutations, 
 26
such as the mutation of two domains of the insulin-like growth factor 1 receptor (IGF-1R) 
involved in a radio-resistant signaling pathway in mouse embryo fibroblasts (Yu et al, 
2003). The previous examples suggest that exposure to toxic agents occurs through many 
different mechanisms, each of which must be fully investigated in order to prevent and/or 
treat the diseases that result.  In addition to the myriad of disease mechanisms that may 
exist, genetic influences may also play an important role in these mechanisms.  Until 
recently, however, the tools and technology necessary to investigate the genetic influence 
on diseases of environmental exposure were inadequate.  The sequencing of the human 
genome has provided us with a blueprint to begin studying the gene-environment 
interactions and the cellular signaling processes that lead to complex, genetically-
associated diseases such as Parkinson’s, Alzheimer’s, and cancer. 
 
Single Nucleotide Polymorphisms (SNPs) 
 One of the most promising immediate benefits of sequencing the human genome 
is the current effort to catalog all of the human SNPs.  Persons displaying a SNP - a 
single nucleotide substitution, deletion, or addition in any given gene or regulatory region 
- are potentially at risk for responding to their environment in a different manner from 
those who contain the consensus “normal” allele of the given gene.  Techniques to 
determine the effects of these polymorphisms are playing an important role in 
pharmaceutical research and in the investigation of disease onset.  An example is the 
cytochrome P450 2D6 (CYP2D6) gene encoding debrisoquine 4-hydroxylase, which is 
involved in the metabolism of many drugs and some neurotoxins.  The poor metabolizer 
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polymorphisms of this gene have been implicated in the pathogenesis of neurotoxin-
induced Parkinson’s disease (Payami et al, 2001).   
 SNPs are the most common type of genetic variation – purportedly occurring at a 
rate of 1 per 1300 bases with a grand total of 1.42 million located in the human genome - 
and are thought to be the most likely candidates for complex polygenic susceptibility to 
disease (Venter et al, 2001; IHGSC, 2001; International SNP Map Working Group, 2001; 
Wolfsburg et al, 2001; Altshuler et al, 2000).  Several disease genes have already been 
discovered; the IT15 gene responsible for Huntington’s disease, the ADAMTS13 gene 
involved in thrombotic thrombocytopenic purpura, the lamin A gene (LMNA) which is 
thought to be the underlying cause of Hutchinson-Gilford progeria syndrome, and the 
CLN2 gene product associated with late-infantile neuronal ceroid lipofuscinosis (LINCL) 
(Huntington’s Disease Collaborative Research Group, 1993; Levy et al, 2001; Eriksson et 
al, 2003; Sleat et al, 1997).  However, most of these genes are linked to rare conditions in 
which the mutation of only one gene seems to cause the disease (International SNP Map 
Working Group, 2001). More complex genetic diseases in which mutations must be 
present in multiple genes are much more difficult to identify.  The identification of such 
genes will require the characterization of all of the existing SNPs in combination with 
association studies of individuals at risk (Lander, 1996; Collins et al, 1997).  
It has already been established that certain SNPs play a pivotal role in the 
manifestation of disease, either by increasing the risk for disease, by preventing disease 
progression, or by affecting transcriptional regulation.  For example, an ApoE4 SNP has 
been shown to increase senile plaque density, rendering this SNP a risk factor for 
Alzheimer’s disease (Hofmann, 2001).  On the other hand, the deletion of base pair 32 of 
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the CCR5 co-receptor gene prevents HIV uptake by T4 lymphocytes, rendering any 
individual possessing this SNP resistant to HIV infection (Lander, 1996; Hofmann, 
2001).  Finally, cases in which a SNP removes, adds, or alters a transcription factor 
binding site which lead to a disease phenotype have been documented (Ponomarenko et 
al, 2002; Ponomarenko et al, 2003). To date, most of the research of genetic disease has 
focused on mutations in single genes, mainly because complex genetic interactions are 
difficult to study (Collins et al, 1997).  However, by performing gene-association studies 
utilizing an SNP catalog, researchers can study the complex interactions between 
multiple genes when exposed to an environmental toxicant (International SNP Map 
Working Group, 2001; Collins et al, 1997).   
 Many SNP databases are available for public use, including the dbSNP and the 
SNP Consortium database, both of which currently contain only human SNP data 
(International SNP Map Working Group, 2001; Smigelski et al, 2000; Wheeler et al, 
2003).  Other more specialized types of SNP databases have also been created, including 
the rSNP_Guide, which allows users to search for novel human transcription factor 
binding sites created, deleted, or altered by SNPs (Ponomarenko et al, 2002; 
Ponomarenko et al, 2003).  By utilizing the vast array of information found in such 
databases, one can begin to explore the probable cause and effect relationship between 
SNPs and specific gene-environment interactions leading to disease susceptibility. 
However, many questions remain to be answered concerning the role of genetic 
polymorphisms in disease progression, including the following:  How do these SNPs 
facilitate disease? Is it a result of the polymorphic gene’s inability to produce its 
functional protein product?  Does the polymorphism destroy some binding sequence 
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required for a particular signaling pathway?  Or does the polymorphism interfere with or 
negate the immune response to that agent? Can prior exposure create a sensitization 
effect, i.e. does it influence genetic susceptibility to a second exposure by worsening the 
effects of subsequent exposure over time? Can genetic susceptibility change or 
breakdown over time as a person ages?  These questions will have to be answered for all 
of the SNPs involved in a disease in order to fully understand the gene-environment 
relationship between exposure and disease.   
 
Environmental Genome Project (EGP) 
In light of all the questions surrounding genetic susceptibility and environmental 
exposure, the NIEHS founded the Environmental Genome Project (EGP) in 1997 (EGP – 
History, 2003).  The purpose of the EGP is to increase the available knowledge and 
information about the effects of environmental exposure and the role genetic variation 
plays in human susceptibility to disease.  Specifically, the EGP focuses on re-sequencing 
parts of the human genome, looking for polymorphisms that may be involved in genetic 
susceptibility to a range of diseases (EGP – Overview, 2003). The EGP has identified a 
group of environmentally responsive genes and categorized them into the following eight 
groups: cell cycle, DNA repair, cell division, cell signaling, cell structure, gene 
expression, apoptosis, and metabolism (EGP – Environmentally Responsive Genes, 
2003).  The goal is to compare and cross-screen the re-sequenced regions of the human 
genome, analyzing each identified polymorphism and determining whether or not it is 
functionally significant. Discovering the identity of the functionally significant 
polymorphisms is crucial to linking genetic susceptibility to specific diseases.  Together 
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with thorough epidemiological surveys, genetic polymorphisms can help determine 
which environmental and genetic factors may interact to produce disease. 
 Although studying gene-environment interactions via SNP comparisons is a 
promising avenue of exploration, some problems may complicate these studies.  For 
instance, disease is not always caused by a single trait; it sometimes involves several 
traits, and the algorithms available may not be able to deduce a correlation between broad 
sets of SNPs and environmental factors.  Therefore, establishing clear-cut relationships 
between particular genes and their environmental inducers may not always be possible.  
These issues will have to be addressed in order to fully understand the mechanisms by 
which genes and their corresponding SNPs are influenced by their environment. 
 
Bioinformatics and the –omics explosion 
 As the human genome project neared its completion, the new field of functional 
genomics began to surface.  Functional genomics encompasses the identification and 
analysis of the entire gene and protein content of an organism (Fields et al, 1999; 
Strausberg and Austin, 1999).  Since then, all of the questions originally proposed under 
the term functional genomics seem to have taken on their own personalities, and have 
each become their own –omics field. The fields of bioinformatics, proteomics, and 
structural genomics, are a few of the fields that have evolved in this manner.  
Developments in these fields will likely facilitate the understanding of the underlying 






The field of bioinformatics collects, analyzes, and disseminates the raw sequence 
data of a genome (D Trends, 2003).  Researchers are currently trying to create better 
analytical software and more powerful algorithms to determine which specific sequences 
correspond to genes or their regulatory regions, and which sections do not play a role in 
the production of proteins or their regulation.  These powerful computer programs will 
allow bioinformaticians to complete an annotated version of the human genome revealing 
the number of genes it contains.  They will also help to predict the regulatory regions, 
functionally significant regions, and transcription factor binding sites in unknown genes.   
 
• Proteomics 
The term “proteome”, coined by Marc Wilkins, refers to the total set of proteins 
encoded by a particular genome (Wilkins et al, 1996).   Even before the determination of 
the complete sequence of the genome, proteomics scientists had already begun to tackle 
the proteome via techniques involving the coupling of 2D polyacrylamide gel 
electrophoresis and chemical composition analysis by mass spectrometry (Wilkins et al, 
1996).  By determining the complete contents of the proteome, proteomics scientists hope 
to discover new protein biomarkers for diseases by examining differences in protein 
expression levels, post-translational modifications, and the differential expression of 
proteins between disease and non-disease states.  With the development of high-
throughput protein analysis methods, such as protein arrays, the identification and 
cataloging processes can be streamlined.  A list of several databases containing 
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information about protein sequences, 2D gel information, and 3D protein structures is 
available at the Expert Protein Analysis System (ExPASy) website (Fig. 1) (James, 
1997). 
 
• Structural Genomics   
With the increasing amount of genomic and proteomic data available, structural 
genomics has found its own niche.  The aim of structural genomics is to characterize the 
structures of representative proteins for each protein family.  Several methods, 
particularly x-ray crystallography and nuclear magnetic resonance (NMR), are used to 
provide a set of reference structures that will serve to help determine the structures of 
similar families of proteins.  The Protein Structure Initiative (PSI) sponsored by the 
National Institute of General Medical Sciences has attempted to create a database of the 
structures of all proteins determined to date (See Fig. 1 - PSI website).  Structural 
genomics scientists can then use the information gained through DNA coding sequences 
to predict primary protein sequence, which can be further analyzed and compared to 
known three dimensional structures by computer homology modeling techniques (Yao, 
2002).   
Computer homology modeling methods play a major role in predicting the tertiary 
structure of proteins by comparing the sequence of a protein of unknown structure to the 
sequences of structures that have already been determined via the use of computer 
databases.  Examples of such databases include Entrez’s Molecular Modeling Database 
and the ModBase database (Wheeler et al, 2003; Yao 2002; Chen et al, 2003).  These 
databases have been employed to determine the physical structure of many proteins and 
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allow public access to the structure and functional domain data generated for known 
proteins.  The identification of a protein’s tertiary structure leading to the recognition of 
common interaction domains, can offer critical information concerning that protein’s 
function.  Recognition of these common binding domains may help to predict novel 
interactions with other proteins or cellular constituents.  Thus, these results could be 
extrapolated from database resources and used to increase the rate at which candidate 
proteins can be examined in biological systems - all based solely on their sequence 
identity and homology to similar proteins.   
In addition to comparing the primary sequence of two proteins, the structural 
databases can be used to compare the tertiary structures of two proteins.  Comparing the 
tertiary structure of proteins may be helpful when comparing two proteins that are 
functionally equivalent, but evolutionarily diverse (Holm and Sander, 1996).  With new 
technologies developing in the field of structural genomics, the goal of structurally 
characterizing the entire proteome may soon be attained, allowing researchers to 
investigate gene-environment interactions at the proteomic level. 
 
Using Bioinformatics to Fuel New Directions in  Environmental Health Research 
Bioinformatics, proteomics, and structural genomics have produced a large 
amount of sequence and structural data very quickly.  The need for interpretation of this 
massive quantity of information has led to the development of many new specific 
disciplines including, but by no means limited to, metabolomics, pharmacogenomics, and 
toxicogenomics.  In addition to these specialized fields, more comprehensive fields such 
as comparative genomics and systems biology have evolved, both of which attempt to 
 34
make more global inferences from a large scale interpretation of all genomes sequenced 
to date (Yao, 2002). 
 
• Metabolomics 
The field of metabolomics attempts to decipher the different interactions between 
signaling pathways by characterizing differences in the metabolome – all of the 
metabolites present at any given time in a biological sample (Muller and Kersten, 2003).   
Metabolomic profiles have been used to determine genotypic differences between 
Arabidopsis thaliana plants through the use of neural networks and to study metabolic 
fluxes in tumor tissue (Taylor et al, 2002; Griffiths and Stubbs, 2003).  Raamsdonk et al, 
has recently shown that genes exhibiting no overt phenotype can be studied using a 
method called functional analysis by co-responses in yeast (FANCY) that detects changes 
in metabolite concentration of a cell rather than an overall growth effect (Raamsdonk et 
al, 2001).  Metabolomics studies have also been shown to be useful in the discovery of 
new toxicity biomarkers, such as the study by Lindon et al, in which 1H-NMR 
spectroscopy was used to identify novel biomarkers in rat bodily fluids (Lindon et al, 
2002).  EcoCyc, a database that describes the metabolic and signal transduction pathways 
of Escherichia coli, and MetaCyc, which contains metabolic and signal transduction data 
for many other organisms have recently been developed (Karp et al, 2000). Since heart 
disease has been linked to aberrant cholesterol metabolism, advances in the field of 
metabolomics could provide major contributions to environmental health researchers 




• Pharmacogenomics  
Pharmacogenomics is a field which aims to identify and characterize the various 
polymorphisms, including SNPs, present in different individuals that may affect a 
patient’s response to a drug (Altman and Klein, 2002).  Examples of an important class of 
highly polymorphic genes include the cytochrome P450 (CYP450) enzymes, many of 
which are responsible for the metabolism of an array of currently available 
pharmaceuticals.  Currently, new technical avenues are being explored to determine a 
patient’s genetic compatibility with a drug before a treatment is prescribed.  This type of 
precautionary testing would protect a patient in the event that he or she possessed a 
polymorphism affecting the metabolism of that drug.  Although it has been suggested that 
less than 1% of SNPs affect the predicted protein coding regions in the human genome 
(Venter et al, 2001), the SNPs that do affect the coding regions can nonetheless have a 
crucial effect on the treatment of patients.  For example, potentially toxic thiopurine 
drugs, such as 6-mercaptopurine which is metabolized by thiopurine methyltransferase 
(TPMT), are administered to children with acute lymphoblastic leukemia (Weinshilboum, 
2001).  Since thiopurines have a very narrow therapeutic index and the levels of TPMT 
are controlled by a common polymorphism, it is necessary to individualize thiopurine 
therapy to prevent fatal thiopurine toxicity (Weinshilboum, 2001).  Other examples have 
also begun to pave the way for the individualization of medical treatment.  The new 
Genentech drug Herceptin is being used to treat only the 20-30% of breast cancer patients 
that overexpress the her-2/neu receptor (Service, 2003).   Advances in the field of 
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 Toxicogenomics is dedicated to the elucidation of the role genes play in response to 
environmental toxicants and stressors (Hamadeh et al, 2002).  NIEHS has recently 
developed the Toxicogenomics Research Consortium (TRC) in conjunction with the 
National Center for Toxicogenomics Microarray Group (NMG) and has charged them 
with the specific tasks of:  identifying sites of genetic variability throughout the human 
genome, developing standards for the current microarray technology being used to assess 
biological responses to environmental stressors/toxicants, and applying this expression 
technology in a manner that helps to elucidate the mechanisms of toxicity produced in 
response to environmental exposure (Medlin, 2002; National Center for Toxicogenomics 
– TRC, 2003).  The TRC’s overall goal is to study the relationship between 
environmental exposure and disease, and to show how these gene-environment 
interactions affect human health.  It may be useful to try to develop genome and 
proteome “fingerprints” of the different toxicants using array technology, in order to 
thoroughly investigate the mechanism of action of these toxins.  The Comparative 
Toxicogenomics Database (CTD) has been launched in order to provide an annotated 





• Comparative genomics 
Comparative genomics encompasses the effort to compare all known complete 
genomic sequences to that of the human genome.  Complete genomes have now been 
sequenced for many of the most popular model organisms currently used in research, 
including the A. thaliana plant (Arabidopsis Genome Initiative, 2000), the worm 
Caenorhabditis elegans (C. elegans Sequencing Consortium, 1998), the fruit fly 
Drosophila melanogaster (Adams et al, 2000), the yeasts Saccharomyces cerevisiae 
(Goffeau et al, 1996) and Schizosaccharomyces pombe (Maier et al, 1992), and the 
laboratory mouse Mus musculus (Mouse Genome Sequencing Consortium (MGSC), 
2002).  The comparative analysis of all of the sequenced genomes allows the 
determination of which human genes have homologous genes in different model 
organisms.  This allows researchers to make more informed decisions about which model 
organism to use for specific studies.  If a particular drug is known to exert toxic effects in 
a mouse due to a murine-specific gene, then another model organism could be chosen 
based on a comparative genomic analysis of several suitable organisms.  Thus, some 
pharmaceutical studies use non-rodent models, such as dogs and primates, in order to 
assess the toxicological effects of certain pharmaceuticals that are not suitable for the 
mouse model (reviewed in Smith et al, 2001). Comparative genomics can contribute to 
environmental health research in much the same way, by offering alternative model 
systems and allowing the elucidation of evolutionarily conserved mechanisms in response 
to disease.  Perhaps similar genetic association patterns may surface between humans and 
non-rodent organisms that are affected by similar diseases. 
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• Comparative Genomics: Sequencing of the Mouse Genome 
In December 2002, the long-awaited draft sequence of the laboratory mouse genome, 
Mus musculus, was finally published (MGSC, 2002).  The comparative genomic analyses 
of the human and mouse genomes may prove to be a major factor in decoding the 
language of the human genome.  Already 342 syntenic segments have been found 
between both genomes, marked differences in G/C distribution between the two 
sequences have been discovered, and upon examination of CpG island content, the 
human genome exhibits about twice as many CpG islands as the mouse genome (MGSC, 
2002).  Differences in the amount of sequence repeats in the mouse and human genomes 
is thought to arise from the activity of transposable elements, which appear to be more 
active in the mouse than in the human (Venter et al, 2001; IHGSC, 2001; MGSC, 2002).  
Since the mouse is the most studied model for human disease, with 99% of its genes 
corresponding to a human homolog, the comparison of the mouse and human genome 
sequences will have a significant impact on the future directions of model-driven research 
(MGSC, 2002).  In addition to the identification of homologous gene pairs, the sequence 
identities of many orthologous disease-associated genes have been compared with an 
overall amino acid identity approximating 90.3% (MGSC, 2002).  These data allow for a 
more refined extrapolation of mouse experimental data to human disease states.   
Currently, there is a Human-Mouse Homology Map sponsored by NCBI that 
allows the comparison of mouse and human homologous segments of DNA.  Several 
websites also offer access to the entire sequence of the mouse genome, including NCBI’s 
Genome Resources website, the Ensembl Mouse Genome Server, and the USC Genome 
Bioinformatics website (MGSC, 2002; Wheeler et al, 2003).  Additional mouse 
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informatics databases can be found at the Jackson, Harwell, and RIKEN websites (See 
Fig. 1) (MGSC, 2002).   
 Aside from comparison applications, the mouse genome sequence will contribute 
to the generation of new knockout mice.  A new transgenic approach by Lois et al. shows 
that an entire mouse can be made to express exogenous genes introduced to the organism 
via a lentiviral vector system (Lois et al, 2002).  This lentiviral vector system could be 
combined with the new siRNA technology (discussed later) to produce knockout mice in 
a much more efficient and cost effective manner than traditional methods.  It may even be 
possible to expand the lentiviral technique for use in fully grown mice to knockout 
embryonic lethal genes in a tissue-specific manner.  Techniques of this caliber would 
provide extremely valuable in vivo data on signaling pathways in the mouse that would 
otherwise be impossible to study.   
 
• Systems Biology 
In addition to the birth of comparative genomics, the availability of the complete 
human and mouse genome sequences has also catalyzed the emergence of systems 
biology, which is the attempt to systematically study all of the physiological processes in 
a cell or tissue by global measurement of differentially perturbed states.  The ultimate 
goal of systems biology is the integration of data from these observations into models that 
will eventually represent and simulate all processes of life, including the induction of a 
diseased state (Ideker et al, 2001; Kitano, 2002).  Advances in proteomics could soon 
make the systems biology approach possible.  Examples of systems biology approaches 
include the galactose metabolism system developed by Ideker et al., the PhysioLab® 
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technology created by ENTELOS, and the Cardiome Project reviewed by 
Bassingthwaighte  (Ideker et al, 2001; Bassingthwaighte, 2000; ENTELOS, 2003). 
 
Current Technology – Global Transcriptional Analysis 
 The increase in new areas of science prompted by the sequencing of the human 
genome coincides with a sudden increase in new technology that can help discover links 
between genes and causation of disease in response to environmental agents.  By looking 
at the expression of a large number of genes at the same time, it is possible to check for 
global trends of expression specific to disease states.  These trends may not be apparent 
to a researcher using traditional time-consuming methods of gene expression 
measurement, such as a Northern blot, which relies on a priori knowledge of regulation 
events.  Several methods have been developed to assess transcription on a global level, 
including DNA microarrays, serial analysis of gene expression (SAGE), and massively 
parallel signature sequencing (MPSS). 
 
• Global Transcriptional Analysis – DNA microarrays 
 One of the most powerful techniques is the DNA microarray, a high throughput 
screening method that measures the effects of a stimulus on the mRNA expression of the 
entire transcriptome in one comprehensive assay (Schena et al, 1995; Fodor et al, 1993).  
Microarray technology utilizes a defined set of probes, each of which represents a 
specific transcript.  Each probe is arrayed on glass slides to form a microscopic high-
density spot.   Total RNA is then isolated from treated and/or control samples and 
differentially labeled with fluorescent dyes.  Next, a mixed population of labeled RNA 
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targets is hybridized to the set of probes.   Finally, the amount of fluorescence is 
measured by image analysis software and the increase/decrease in gene expression is 
determined via statistical analysis of fluorescence intensity.  Several databases have been 
created to store microarray data, making it available to the public.  These include but are 
not limited to the Stanford Microarray Database and the NCBI Gene Expression Omnibus 
database (See Fig. 1).   
An attractive advantage to the microarray assay is that the large amounts of 
expression information obtained through one assay can save a tremendous amount of 
time by eliminating the need for blind usage of Northern blotting, RT-PCR, western 
blotting, and enzymatic assays to analyze gene expression.  These time-consuming 
techniques can now be utilized on a smaller scale, as a subsequent validation method, to 
provide connections for the underlying mechanisms of the signaling pathways (Chin and 
Kong, 2002).  In addition to the standard use of the assay for gene expression, genomic 
microarrays could potentially be employed to detect single nucleotide polymorphisms 
(SNPs), since the hybridization between mismatches, even of a 1 base pair magnitude, 
can be detected upon quantification of the hybridized probe or by enzymatic treatment in 
certain systems (Kolchinsky and Mirzabekov, 2002; Hacia and Collins, 1999). 
As more human genes are identified and characterized, the development of 
microarrays can be tailored to include specific subsets of related genes that might be of 
interest to a researcher.  One example would be the development of carcinogenesis chips 
that contain oligo probes specific for all known genes involved in cancer pathology.  
Toxicology laboratories in the United Kingdom have recently developed a set of 
toxicology tailored microarrays known as ToxBlot and ToxBlot II, which are specifically 
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for use in toxicogenomic assays (Pennie, 2000; Pennie, 2002).  Subset specific 
microarray databases, such as the Comparative Toxicogenomics Database (CTD) which 
contains toxicogenomic microarray data, are also under development (Mattingly et al, 
2003; Medlin, 2002).  These types of specialty-tailored microarrays could become more 
and more important for the initiation of hypothesis-driven research as we extrapolate 
information about the individual genes comprising the human genome. 
One of the most useful applications of microarrays is the elucidation of uniquely 
affected transcripts in response to a stimulus, producing a so-called fingerprint pattern.  It 
has recently been shown that microarray data can be useful in diagnosing diseased states 
in rats by examining the gene expression pattern of white blood cells, producing a 
fingerprint expression pattern unique to a specific disease state (Tang et al, 2001).  
Previous studies have also shown that different inflammatory diseases such as 
rheumatoid arthritis and inflammatory bowel disease exhibit a differential display of gene 
expression upon microarray analysis (Heller et al, 1997).  Moreover, lesions of multiple 
sclerosis subjected to microarray analysis also produced expression profiles different 
from that of normal tissue from the same individual (Whitney et al;. 1999).  Most 
recently, several laboratories have been able to identify a disease state and even predict 
the prognosis of an individual based on the patient’s gene expression profile (Perou et al, 
2000; Sorlie et al, 2001; Brenton et al, 2001; Gruvberger et al, 2001).  These molecular 
fingerprints of disease produced by microarrays may be able to revolutionize the way we 
diagnose disease states. Diagnostic microarrays could also be used to identify and assess 
the severity of environmental exposure even if symptoms have not yet surfaced.  With 
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more research pending, this type of disease diagnosis may become an increasingly 
powerful tool in the individualization of health care treatment.   
In addition to the fingerprint approach to microarray diagnostics, microarrays 
could also be instrumental for facilitating the identification of biomarkers specific for 
many different types of disease processes (Gerhold et al, 2002; Chin and Kong, 2002).  It 
has been demonstrated that microarrays can detect alterations in gene expression in 
pathological states, such as microbial colonization of the gut and the onset of 
inflammation (Heller et al, 1997; Hooper and Gordon, 2001).  Gel pad microarrays have 
even been used for identification of all types of pathogens - viruses, bacteria, prokaryotes 
– and the determination of tuberculosis antibiotic resistance, genetic mutations, SNP 
markers, and chromosomal rearrangements (Kolchinsky and Mirzabekov, 2002).  The 
identification of new biomarkers will allow for the expansion of the available cache of 
simple diagnostic tests that can be performed in the laboratories at hospitals, instead of 
relying on more technically complicated diagnostic methods, rendering faster and more 
definitive results. 
Microarray technology also has practical uses and applications in the 
environmental health research laboratory.  Screening patients for a genetic risk factor is 
currently feasible only for a small subset of rare diseases that depend on the mutation of a 
single gene.  With the newly emerging genetic technology, it is possible that the list can 
be expanded to include more diseases, particularly those that are influenced by more than 
one gene, such as diseases resulting from low-dose, chronic exposure to a hazardous 
agent.  This could potentially save many lives by identifying the diseases much earlier, 
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allowing doctors to prevent and/or pre-treat diseases before symptoms appear and the 
disease’s course has already damaged the patient’s body beyond repair (Grody, 2003).   
As there is always a down side to every promising technique, there are also plenty 
of disadvantages plaguing the microarray.  The microarrays currently used in most 
laboratories are not extremely sensitive and may exhibit probe hybridization technical 
problems (Kolchinsky and Mirzabekov, 2002).  The reliability of the assay is 
compromised for genes with repetitive sequence elements or nucleic acids that strongly 
favor a secondary structure (Hacia and Collins, 1999).  Additionally, since mRNA is 
transiently expressed, the expression information obtained through microarray analysis is 
limited to a “snapshot” of a biological process.  Furthermore,  early microarray data has 
not been continuously subjected to a set of globally accepted standards, and therefore 
much of the microarray data already generated and available in the public databases may 
be non-comparable or misleading if not examined carefully and analyzed using the 
appropriate statistical methods (Nadon and Shoemaker, 2002). 
Microarray technology has also been criticized for creating a large number of 
false positives and negatives, for difficulty in reproduction of results between assays and 
laboratories, and for providing too much information for realistic interpretation.  The 
Microarray Gene Expression Data (MGED) Society has begun to address some of these 
issues, and is currently trying several approaches such as:  developing standards that will 
help to reduce variability between assays and laboratories which would increase 
reproducibility, requiring annotation of microarray data provided in databases – the 
minimal information about a microarray experiment (MIAME) standards, and developing 
computer software allowing microarray data to be exchanged between laboratories 
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(Brazma et al, 2001 ).  With these improvements looming in the not-so-distant future, 
microarrays should prove to be an extremely useful tool in the quest for understanding 
gene-environment interactions.  
 
• Global Transcriptional Analysis – MPSS and SAGE 
 Although DNA microarrays are the most common way to examine transcription 
on a global scale, MPSS and SAGE offer certain advantages over the DNA microarray.   
The SAGE technique relies on a set of gene-specific probes complexed with streptavidin 
beads, each containing a specific tag sequence.  The probes and tag sequences are cleaved 
from the beads by restriction enzymes and combined to form a unique set of markers for 
each transcript.  The transcripts are subjected to PCR and sequenced to determine their 
identity (Velculescu et al, 1995).  A SAGEmap database has been developed for the 
dissemination of SAGE data (See Fig. 1) (Lash et al, 2000).  Another technique, MPSS, 
is very similar to SAGE.  The designers of MPSS have generated a large set of 
microbeads, each containing a unique tag attached to a gene-specific probe.  The beads 
containing the tag-probe complex are then mixed with RNA, allowing for hybridization 
between the RNA and its specific tag-probe complex, and placed into a flow cell where 
up to a million transcripts can be sequenced simultaneously (Brenner et al, 2000).   
There are a few advantages to using the SAGE or MPSS approaches over 
microarrays.  One advantage is that SAGE and MPSS are thought to be more sensitive 
than microarrays.  They can detect very low levels of transcripts in a system, whereas 
microarray experiments may tend to omit some of these low level transcripts.  Since the 
quantitation of MPSS relies on counting the number of beads with a specific tag instead 
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of hybridizations between a probe and target DNA that may or may not be absolute, the 
statistical analysis of MPSS is far more robust than that of DNA microarrays (Brenner et 
al, 2000).  MPSS is also a much faster technique for global transcriptional analysis than 
SAGE, since a million transcripts can be sequenced at a time.  MPSS also simplifies 
many of the steps required for preparing a DNA microarray experiment, thus reducing the 
margin of error in an MPSS experiment. 
 
Current Technology - siRNA 
 siRNA can also be very useful for the elucidation of signaling pathways induced 
by different environmental agents, particularly now that the complete human genome 
sequence is available.  RNA interference (RNAi) is a naturally occurring mechanism in 
which the presence of dsRNA can lead to gene silencing through siRNA intermediates.  
siRNAs are 21-23 base pair sequences that are created from larger dsRNA molecules by 
an enzyme of the RNase III family called Dicer.  The siRNA fragments then associate 
with a nuclease complex termed the RNA-induced silencing complex (RISC).  RISC 
unwinds the siRNA fragments and allows the single-stranded fragment to target 
complementary RNA inside a cell, which somehow activates the nuclease activity of the 
RISC complex (reviewed in Ambion, 2003).   
RNAi was first discovered in the worm, and has been a commonly utilized 
technique in the invertebrate world (Fire et al, 1998; Zamore, 2001).  Until recently, 
RNAi was thought to be an application that could only be used in invertebrate studies, 
since a double stranded RNA greater than 30 base pairs in length seemed to activate the 
PKR kinase anti-viral mechanism and induce apoptosis in mammalian cells (Ambion, 
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2003; Zamore, 2001).  However, it was recently discovered that the 21-23 nucleotide 
siRNA fragments could bypass the apoptotic mechanism and produce a gene-silencing 
effect in mammalian cells (Elbashir et al, 2001).  Although the precise details of the 
mechanism of siRNA-silencing are not entirely known, it is still an extremely useful 
laboratory technique.  The short siRNA fragments can be synthetically produced by 
silencing vectors, and transfected into mammalian cells, resulting in a decrease of a 
specific protein from the system (Elbashir et al, 2001).  An advantage of siRNA over the 
conventional practice of over-expressing dominant-negative mutants in cellular systems, 
is that the siRNA removes endogenously expressed mRNA.  This method is also much 
easier than creating knockout mutations in cell lines, since it requires only the synthesis 
of siRNA fragments and a transfection.   
 Several labs have recently suggested that siRNA technology could have clinical 
applications, such as the inhibition of HIV-1 replication, in addition to its research 
applications (Jacque et al, 2002; Novina et al, 2002).  Capodici et al. have shown that 
they can inhibit HIV-1 infection and replication by transfecting primary CD4+ T cells 
with HIV-1 specific siRNA (Capodici et al, 2002).  In addition, Qin et al. have developed 
a lentiviral-mediated delivery system for siRNA complementary to CCR5 mRNA, the 
main HIV-1 co-receptor in primary CD4+ T cells (Qin et al, 2003). This application 
seems to lead to the prevention of HIV-1 infection, mimicking the natural immunity to 
HIV-1 seen in individuals who lack both CCR5 co-receptor genes (Qin et al, 2003; Dean 
et al, 1996).  Future siRNA research utilizing approaches such as these, could lead to the 
use of siRNA and retroviral gene therapy applicable not only to HIV-1 infection, but to 
environmentally-induced disease states as well. 
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siRNA could become a very powerful tool for the environmental health research 
community.  Once the sequence of a particular gene that responds to an environmental 
toxin is known, siRNA can be easily exploited to reveal the consequences of removing 
that protein from a cellular system.  Other suggested uses for the siRNA technology that 
could benefit environmental health research include the development of siRNA chips.  
These chips would consist of an array of unique siRNA probes fixed to a tissue culture 
slide.  Cells could then be grown on these chips to show a range of siRNA suppression 
based on the siRNA vector the cell takes up, allowing for a high-throughput format for 
siRNA studies (Zamore, 2001).  In addition, a new type of ssRNA, termed microRNA 
(miRNA) or small temporal RNA (stRNA), is thought to function in translation 
suppression. These ssRNA molecules may be useful for genetic-silencing experiments as 
well (Zamore, 2001; Dennis, 2002). 
 
Emerging Technology – Peptide/Protein Microarrays 
 With the recent push towards high throughput technology, it only seems natural 
that peptide arrays would follow the advent of DNA microarrays.  The set up of a peptide 
microarray is very similar to that of a DNA microarray.  In both cases, a set of unique 
probes, or capture agents, are attached to a glass slide, or some other form of solid 
support system.  The main difference between the two assays is the type of capture agent 
that is attached to the slide.  In the protein microarray, the capture agent can range from 
antibodies, epitopes, and small molecules to sets of recombinant proteins (Tyers and 
Mann, 2003).  On the contrary, cDNA or oligonucleotide probes are used in DNA 
microarrays.  The different probes in a protein microarray are chosen depending on what 
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type of assay the researcher wants to run.  Examples of peptide microarray assays include 
binding assays, enzymatic activity assays, protein identification assays, and cell adhesion 
assays (Reimer et al, 2002; MacBeath, 2002).  
One potential application of a protein microarray is the enzymatic kinase assay.  
In this assay, a purified 32P-labeled kinase can be applied to an array utilizing peptides as 
capture agents. Each protein probe that is phosphorylated by that specific kinase would 
then bear the radio-label (MacBeath and Schreiber, 2000).  Alternative uses of the protein 
microarray include the use of antibody probes, which could detect specific proteins from 
a mixed solution of total protein isolated from a test subject (Belov et al, 2001).  The 
development of yet another peptide microarray assay includes the placement of different 
proteins onto the glass slide and washing the slide with a mixture of differentially 
fluorescent labeled proteins in order to determine protein binding interactions (MacBeath 
and Schreiber, 2000).  Assays such as these could advance the discovery of biomarkers 
important for the identification of diseased-state phenotypes. These assays may also help 
elucidate exciting new protein-protein interactions. 
Although peptide microarray technology is still in its infancy, the advantages are 
apparent.  In particular, the arrays offer a high-throughput advantage over traditional 
methods such as yeast-two hybrid screens, fluorescence resonance energy transfer 
(FRET), and the traditional biochemical assays coupled to mass spectrometric analysis 
(reviewed in Phizicky et al, 2003).  Protein microarrays can also help fill in the gaps left 
by DNA microarrays, since DNA arrays are indifferent to some forms of genetic 
regulation, such as post-translational regulation and protein degradation.  The 
development of solid protein profiling techniques and applications would allow 
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researchers to supplement the information gained through DNA microarray studies.  In 
addition, a global analysis of the entire proteome could lead to the quick discovery of 
protein-protein interactions that may have taken years to notice with a small scale 
approach. 
Currently, however, it is not yet technically possible to determine the entire 
content of a proteome with a protein microarray.  Several complicating factors, such as 
the existence of unknown differential splice variants and post-translational regulation 
events undergone by many proteins, make it difficult to develop capture agents for these 
currently unknown proteins.  Difficulties also arise during the production of the capture 
agents that are needed to specifically interact with only a single protein.  Another 
disadvantage of protein arrays that measure specific binding to a set of capture agents is 
that attachment to the slide must not alter the structure or function of the capture agents 
(MacBeath, 2002).   Yet another issue relates to the difficulty of synthesizing the proteins 
on the glass slide, possibly creating a bias as to which proteins get studied, e.g. the easiest 
ones to synthesize on the slide.  Other concerns have been voiced about the difficulties of 
miniaturizing the protein microarrays while maintaining sensitivity and the need for 
algorithms that are advanced enough to handle a protein array format.   
One of the most important issues of implementing protein microarrays is the 
difficulty in producing large numbers of highly pure recombinant proteins.  However, 
recent advances in protein complex purification involving the tandem affinity purification 
method combined with RNAi (known as iTAP) by Forler et al. are a step in the right 
direction (Forler et al, 2003).  The sequence of the human genome may also help to 
remediate this shortcoming by allowing the development of a perfectly normalized 
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human cDNA clone library spanning the entire proteome.  In fact, the FlexGene 
Consortium has recently announced their mission to develop a complete cDNA collection 
specifically for this purpose (Tyers and Mann, 2003). 
 New advances in nanotechnology may also help to overcome many of the 
technical issues with the newly developing protein arrays.  Some of these new advances 
include the research of Ouyang and colleagues, who have demonstrated a soft-landing 
mass-spec technique to separate protein mixtures and spot proteins in a microarray 
format.  An array of proteins was created by their soft-landing technique that allowed 
proteins to retain their biological activity (Oyuang et al, 2003).  Other advances in 
nanotechnology that may assist protein array implementation include the development of 
new protein capture agents, such as the mixed-element capture agents (MECAs) 
developed by Bachhawat-Sikder and Kodadek.  MECAs comprised of two small proteins 
attached together with a variable linker region and were shown to bind their target 
molecules with high affinity and sensitivity, making them good candidates for protein 
array capture agents (Bachhawat-Sikder and Kodadek, 2003). 
 Despite the immaturity of peptide microarray technology, results from primitive 
protein array assays have already indicated the usefulness and incredible versatility of the 
assay.  Analogous applications to those of DNA microarrays, such as using protein 
profiling to obtain a characteristic fingerprint of a single disease, have already been 
developed. In fact, protein microarray profiling has recently been used to fingerprint 
different leukemia types, which may someday become a widely used diagnostic tool 
(Service, 2003; Belov et al, 2001).  In addition to fueling new research applications, 
protein profiling could soon take its place next to the DNA microarray as a new 
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diagnostic tool. Together with DNA microarray technology, peptide microarrays may 
also help to revolutionize many aspects of the health care field, including applications to 
diagnostics and assistance with the personalization of disease treatment. 
 
Biosecurity and Bioterrorism
We have all probably noticed the increased attention focused on bioterrorism in 
the United States since the attacks of September 11, 2001 and the subsequent reports of 
inhalation anthrax in October, 2001 (Jernigan et al, 2001).   Traditionally, biowarfare 
research has mainly been conducted by military scientists in government facilities.  
However, in 2003 alone, approximately $1.75 billion has been poured into biological 
weapons research, much of which is being allocated to the private and academic sectors 
to develop biowarfare research programs and facilities (Fauci, 2002).  Biosecurity and 
bioterrorism are a definite concern for the environmental health research community.  In 
response to the increasing threat of the use of biological and chemical weapons in a 
terrorist attack, the Centers for Disease Control and Prevention (CDC) has compiled a list 
of biological agents that would most likely be used in a terrorist attack (Rotz et al, 2002) 
(See Table 1).  The dissemination of aerosolized particles of many of these agents into 
the environment is considered to be extremely dangerous.  Therefore, it is the 
responsibility of environmental health researchers to help develop new methods of 
detecting chemical-biological (CB) agents and aide in the advancement of toxicology and 
genetic interaction studies pertaining to novel vaccines and treatments.  
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Preparedness in the Case of a CB Attack 
In the past, emphasis has been placed on the ability of health care facilities to 
communicate with each other and coordinate treatments in the event of a CB attack.  
Such emphasis has prompted the development of many new training and preparedness 
programs, including preparedness programs at the state and federal levels and non-
governmental professional programs, such as the Clinicians’ Biodefense Network (CBN). 
The CBN aims to link clinicians to health experts and biomedical researchers, allowing 
for rapid communication and the distribution of updated information concerning 
biodefense during times of crisis (Radonovich, 2002).  However, education and 
preparedness of healthcare workers is not enough to protect the mass population.  
Today, more emphasis has been placed on developing countermeasures in the 
event of a biological attack, and there has been an overwhelming push by the government 
and the public for further research into biosecurity efforts.  It thus follows, that the 
determination of the gene-environment interactions that can occur in response to 
biological or chemical weapon attacks should be a major priority in the environmental 
health research community. The development of rapid and standard laboratory tests 
detecting exposure to a specific kind of CB agent that could be widely and economically 
distributed to health care facilities would greatly enhance our ability for the early 
detection and response to certain types of potential attacks.  Candidate assays for these 
tests include the identification of specific biomarkers for exposure to CB weapons.  
Biomarkers could easily be assayed for changes in exposed victims and would greatly aid 
in the early clinical recognition of such an attack. With the recent anthrax attacks, an 
early screening method for potential biomarkers specific to anthrax infection applied to 
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all who were suspected of anthrax exposure would have improved the ability of the 
nation’s public health system to respond, and in turn could have possibly saved lives and 
prevented the needless distribution of large amounts of Cipro (ciprofloxacin, the 
antibiotic used to treat anthrax infections) (Jernigan et al, 2001; Rosenberg, 2003).  With 
the information gained from the completion of the human genome sequence, and the 
multitude of emerging technologies available, there are many opportunities for the 
exploration of bioterrorism countermeasures. 
 
Preparedness in Case of a CB Terrorist Attack-Mass Vaccination 
Many of the vaccines and treatments used to prevent the spread and disease 
manifestations of potential bioterrorism agents were manufactured over 20 years ago; in 
the case of the smallpox virus, the vaccine used to eradicate the disease in 1980 is the 
only currently available vaccination (Lofquist et al, 2003; Fauci, 2002; WHO, 1980).  
Previous data has suggested that a smallpox outbreak would spread slowly (Eichner and 
Dietz, 2003).  The current recommended public health response to a smallpox outbreak is 
a ring vaccination strategy in which individual cases are isolated, quarantined, and their 
contacts vaccinated (Whitley, 2003).  However, some scientists have shown that this 
approach may not be as effective as an immediate mass vaccination in the event of a 
biological attack on an urban center (Kaplan et al, 2002), suggesting that new strategies 
should be considered.   
 Several setbacks have surfaced during discussions concerning vaccination to 
protect the mass population in the event of a biological attack.  One of the most important 
is the lack of interest from pharmaceutical companies to develop and produce vaccines 
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for biological warfare agents.  Most of the larger companies are unwilling to develop 
these vaccines because of financial concerns, liability issues, efficacy questions, and 
regulatory limitations (Rosenthal and Clifford, 2002; Langford and Myers, 2002).   
Another concern is the high rate of complications in the vaccines that have been licensed 
and are used exclusively in the military, but not in the general public. The high 
occurrence of adverse effects in such a small population (reported to be >30% in some 
instances) suggests that the benefits of vaccination in the case of a potential threat may 
not outweigh the risks of vaccine complications (Frey et al, 2002).  However, 
identification of SNPs in certain populations via microarray analysis may help to 
determine which subset of the population should not be vaccinated in preparation for a 
biological attack.  The identification of these individuals would result in a decrease in the 
number of unnecessary complications/deaths that could occur in the event of a mass 
vaccination, should a bioterrorism situation arise.  Other measures would need to be 
taken to protect these individuals.  Although the United States currently has licensed 
vaccines for smallpox and anthrax, it does not have these for many of the other agents 
listed as potential biological warfare agents by the CDC and researchers are working 
fervently to develop them (See Table 1).  Newly developed Ebola vaccines have recently 
been shown to protect mice, guinea pigs, and non-human primates from lethal doses of 
the virus (Vanderzanden et al, 1998; Xu et al, 1998; Sullivan et al, 2000). 
In addition to vaccination, other methods of preparedness have been discussed.  
Recently, a set of guidelines has been published by the CDC’s National Institute for 
Occupational Safety and Health (NIOSH), outlinining the procedures building officials 
should follow to protect private, public, and government buildings from chemical, 
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radiological, and biological terrorism (NIOSH, 2002).  A second set of guidelines has 
been published by the Office of Health and Safety to ensure laboratory security and 
emergency response preparedness for laboratories that work with CB agents deemed fit 
for terrorist attacks (Richmond and Nesby-O’Dell, 2002).  In order to further protect 
building environments from a CB attack, engineers have also been trying to develop a set 
of biomaterials that can metabolize CB agents.  The approach is designed to allow the 
incorporation of these materials into equipment, such as the countertops of an office 
building or the sorting machines used in post offices (reviewed in Russell et al, 2003).  
The development of such materials combined with the protective measures outlined by 
NIOSH and OHS could allow for widespread protection from attacks in almost any 
building or environment, while diminishing public fear of an attack. 
 
Early Detection of CB Agents in the Environment 
Although much has been discussed concerning early disease recognition, 
improved surveillance/communication methods, and the limitation of potentially sensitive 
scientific information (Zilinskas and Tucker, 2002; Atlas et al, 2003; Chyba, 2001; Kwik 
et al, 2003), less has been suggested concerning our ability to detect a CB attack before 
clinical disease is recognized in victims.  The early detection of the agent itself in the 
environment, which could help prevent the spread of the infection in the case of a 
biological attack and limit the number of victims affected by the agent, would be more 
advantageous than the early detection of diseases caused by these agents.  
One of the most effective ways to deliver a biological weapon is the release of 
aerosolized particles into the environment. Implementing a biological agent monitoring 
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system that can detect a CB agent by sampling the air would greatly enhance our ability 
to evacuate enclosed areas deemed ideal for CB attack (Wyatt, 2002).  Testing has 
recently begun at San Francisco International Airport for one of the first CB agent 
defense systems (Larkin, 2003).  The system, known as PROACT (Protective and 
Response Options for Airport Counter-Terrorism) and produced by Sandia National 
Laboratories in Livermore, CA, is designed to monitor the air at large indoor public 
meeting areas for CB agents as a measure to deter chemical attacks such as the 1995 sarin 
attack in the Tokyo subway system (Frischknecht, 2003; Larkin, 2003).  Details of the 
mechanism of action of the device have not yet been disclosed. However, if it proves to 
be reliable, the device may spread to other airports across the nation. 
Immunological methods to detect biological warfare agents are also being 
investigated for use in an early warning detection system.  A miniature biochip system 
based on an ELISA assay has recently been developed by Stratis-Cullum et al. In this 
system, air samples containing aerosolized spores of Bacillus globigii were applied to a 
minature ELISA biochip, where a novel alkaline phosphatase substrate, 
dimethylacridinone phosphate (DDAO-P) was cleaved by an alkaline phosphatase (AP) 
enzyme (Stratis-Cullum et al, 2003).  The DDAO formed as a result of AP cleavage can 
be excited by a miniature diode laser and the voltage output read on a laptop computer. 
Although this highly sensitive, portable device was used for the detection of B. globigii 
spores, it could be used to detect other aerosolized forms of biological weapons.   
Another immunoassay, the multiplexed liquid array, has been shown to be useful 
in the simultaneous detection of many different biological agents (McBride et al, 2003).  
McBride and colleagues used a set of polystyrene microbeads conjugated to biowarfare 
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agent-specific antibodies, each of which displays a unique spectral pattern.  Once the 
microbeads are exposed to antigen, a secondary antibody conjugated to the fluorescent 
reporter phycoerythrin (PE) is applied, and the beads are assayed in a flow cytometer.  
The presence of the unique spectral pattern detects the type of antibody that reacted with 
a biowarfare agent, while the PE is detected simultaneously to quantify the amount of 
agent present in the air.  These types of assays are candidates for use in early warning 
detection systems because they are rapid, easily detected, and are part of a portable unit.   
 
Environmental Health Research, the Human Genome Project, and Biosecurity 
The DNA microarray and protein microarray applications discussed previously 
can also be applied to bioterrorism.  These techniques can be useful in leading us towards 
unique physiological responses that may occur when an individual has been exposed to 
these agents, providing scientists with a much narrower spectrum of therapeutic targets to 
focus on during their research. The genomes of several potential biowarfare agents have 
already been sequenced, including that of Bacillus anthracis (Read et al, 2003).  
Microarrays have already been used to study the effects of the B. anthracis virulence 
factors atxA and acpA.  These studies suggest that atxA is a global regulator of many new 
genes that could potentially exhibit virulence effects (Bourgogne et al, 2003). By treating 
human protein arrays with a mixture of proteins from a biowarfare agent, one could infer 
interactions between the proteins of the agent and human proteins, leading to new drug 
targets, new signaling pathways, and new routes of infection.  Implementing the use of 
databases containing collections of array data would allow the expression effects of these 
agents to be cross-referenced, possibly leading to the identification of a few candidate 
 59
therapeutic targets that could be used for the treatment of diseases induced by CB agents.  
As suggested earlier, microarrays may also prove to be important in the identification of 
novel or weaponized infectious agents.  Microarrays played a large role in the 
identification and characterization of the Severe Acute Respiratory Syndrome (SARS) 
coronavirus that plagued China, Canada, and Vietnam, among others (Ksiazek et al, 
2003).  Additional applications include the use of microarrays to differentiate between a 
large spectrum of possible viral infections and to determine the genotype of these 
pathogens (Wang et al, 2002). 
 
Novel Treatments in a CB attack 
In addition to being concerned about preparedness in the case of an attack, novel 
treatments of diseases caused by such CB agents should be thoroughly investigated.   One 
of the easiest ways to weaponize a bacterial strain for use in a biological warfare attack is 
to engineer antibiotic resistance genes into the strain.  Since this is not an extremely 
difficult task, the need for non-antibiotic treatment of weaponized strains of biological 
agents is an important matter.  A novel approach to treating victims of a CB attack, 
developed by Fischetti, is the use of purified bacteriophage lysins to specifically lyse 
targeted bacteria, including those exhibiting antibiotic resistance.  Fischetti’s group 
demonstrated that PlyG, a gamma phage lysin specifically targeting B. anthracis, 
effectively killed spores in vivo.  PlyG treated mice had a 72% survival rate versus a 10% 
survival rate for untreated mice (Fischetti, 2003). In addition to the bacterial lysin 
approach, it may also be possible to deliver siRNA through a viral gene therapy 
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mechanism as a therapeutic countermeasure to interfere with an agent’s ability to 
replicate.   
 
Future Directions 
 In order for scientists to get the maximum benefit from the current technology 
available, significant technological and organizational improvements must be made.  
Advanced software is required for bioinformaticians to accurately recognize common 
binding domains, promoter regions, and transcriptional regulatory elements.  The 
development of user-friendly, organized databases providing DNA and RNA sequences, 
protein interactions, protein structures with correct annotations, microarray data, and a 
variety of animal genome sequences appear necessary to solve the puzzle of signaling 
pathways, which can have profound effects on human disease states.   
There are also many different forms of data that need to be explored on a multi-
level scale.  Genomes, transcriptomes, proteomes, and metabolomes are not separate 
entities and each –omic level must be taken into consideration when integrating the 
different types of information available.  For example, many proteins are multi-functional 
and may act at the level of transcription as well as participating in a cellular signaling 
cascade. We must be able to view each piece of information from a global standpoint. 
 With the surge in the development of new techniques and fields of expertise, the 
environmental health research community can use the information provided by the 
genetic code to its advantage.  The improved identification of environmentally hazardous 
agents via gene and protein expression analysis as a diagnostic tool in health care 
facilities could soon become a reality, allowing for better assessment of environmentally 
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induced health risks and ultimately more accurate treatments.  The elucidation of 
biological responses to toxic environmental agents and the mechanisms by which these 
agents cause cellular damage may aid in developing new drug targets and/or novel 
therapeutic options.  Transcriptome expression patterns could soon be identified for 
individual toxicants and stressors, which may improve exposure assessment methods.  
Additionally, the discovery of new biomarkers activated in response to environmentally 
hazardous agents and the use of array expression analysis may soon be indispensable 
tools for diagnosing a disease, determining its stage, predicting its course, and thus 
dictating its treatment on an individual basis.  The identification of susceptibility factors 
through SNP screening could lead to a better assessment of risk factors for potentially 
susceptible individuals and possibly even lead to prevention of adverse effects or even 
some diseases altogether. 
 
Concluding Remarks 
In conclusion, the elucidation of a first draft of the human genome sequence has 
provided the environmental health research community with a wealth of information and 
a genetic framework that can greatly contribute to our understanding of gene-
environment interactions.  Determining the actual extent of polymorphisms and assigning 
function to the remaining 40% of predicted proteins with unknown molecular function 
(Venter et al, 2001), are only a few examples of the challenges still ahead.  However, 
with the current information available and by using these new techniques and the 
expertise of those involved in the emerging fields of environmental health research, we 
can close in on our common goal of providing the world with better treatments and 
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knowledge to prevent the atrocious diseases that can result from exposure to harmful 




We would like to thank Dr. Jose Centeno of the Armed Forces Institute of Pathology and 
Matthew Hirsch of West Virginia University for their comments and suggestions 
regarding this manuscript.  
Figures and Tables 
 
Figure 1:  Webguide to Bioinformatics Sites and Useful Database Links 
 
Bioinformatics Sites 
HGP Timeline       http://www.ornl.gov/TechResources/Human_Genome/project/timeline.html
Environmental Genome Project     http://www.niehs.nih.gov/envgenom/home.htm
NCBI Gene Expression Omnibus Database   http://www.ncbi.nlm.nih.gov/geo
FlexGene Consortium cDNA database    http://www.hip.harvard.edu
NCBI Genome Resources      http://www.ncbi.nlm.nih.gov/genome/guide/mouse/
University of Southern California Genome Bioinformatics     http://genome.ucsc.edu
Cancer Genome Anatomy Project    http://cgap.nci.nih.gov
HyperCLDB - Cell Line Database    http://www.biotech.ist.unige.it/cldb/indexes.html
Gene Ontology Consortium     http://www.geneontology.org
 
SNP Sites 
dbSNP        http://www.ncbi.nlm.nih.gov/SNP
SNP Consortium Database     http://snp.cshl.org
rSNP_Guide       http://www.mgs.bionet.nsc.ru/mgs/systems/rsnp/
Debbie Nickerson Lab SNP catalogs    http://droog.mbt.washington.edu
 
Proteomics and Structural Genomics Sites 
Entrez Molecular Modeling Database       http://www.ncbi.nlm.nih.gov/entrez/query.gcfi?db=Structure
ModBase Database      http://guitar.rockefeller.edu/modbase
Ann Stock Lab - Structural Genomics Links     http://stock.cabm.rutgers.edu/links/
Protein Structure Initiative     http://www.structuralgenomics.org/
ExPASy Molecular Biology Server    http://us.expasy.org/
RCSB Protein Data Bank     http://www.rcsb.org/pdb/
Danish Cancer Society - 2D Protein Database   http://proteomics.cancer.dk/
Philip Andrews Lab - Proteomics Links    http://www.proteome.med.umich.edu/andrewslab/links/proteomics.html
TRANSFAC - Transcription Factor Database   http://www.gene-regulation.com/
 
Pharmacogenomics Sites 
HGP – Pharmacogenomics     http://www.ornl.gov/TechResources/Human_Genome/medicine/pharma.html





Toxicogenomics Research Consortium    http://www.niehs.nih.gov/dert/trc/home.htm
National Center for Toxicogenomics Microarray Group  http://www.niehs.nih.gov/nct/nmc.htm
Toxicology and Environmental Health    http://www.sis.nlm.nih.gov/Tox/ToxMain.html
 
Comparative Genomics and Systems Biology Sites 
Harvard-Lipper Center for Computational Genetics   http://arep.med.harvard.edu
Princeton Model Organism Virtual Libraries      http://www.molbio.princeton.edu/scientific.php
ENTELOS - Virtual Obesity Model    www.entelos.com
Virtual Heart Project      www.physiome.org
 
Mouse Genome Informatics 
Ensembl Mouse Genome Server    http://www.ensembl.org/Mus_musculus/
The Jackson Lab - Mouse Informatics    http://www.informatics.jax.org
Harwell Mouse Informatics     http://www.har.mrc.ac.uk/
RIKEN Mouse Informatics     http://genome.rtc.riken.go.jp/
 
Microarray Sites 
The Brown Lab Microarray Database    http://cmgm.stanford.edu/pbrown/index.html
Microarray Gene Expression Database (MGED)   http://www.mged.org
Stanford Microarray Database     http://genome-www5.stanford.edu/MicroArray/SMD 
Microarray Gene Expression Data (MGED) Society  http://www.mged.org
Telechem International E-Library    http://arrayit.com/e-library/
The Institute for Genimic Research (TIGR)   http://www.tigr.org
TIGR Microarray Software Suite     http://www.tigr.org/software/tm4
TIGR Gene Indices      http://www.tigr.org/tdb/tgi
TIGR Microarray Tools      http://pga.tigr.org/tool.shtml
MIAMExpress       http://www.ebi.ac.uk/miamexpress/
The Churchill Lab Microarray Statistical Software  http://www.jax.org/staff/churchill/labsite/software/index.html
MIAME Checklist      http://www.mged.org/Workgroups/MIAME/miame_checklist.html
 
SAGE and MPSS  Sites 
NCBI's SAGEmap      http://www.ncbi.nlm.nih.gov/SAGE/
Arabidopsis MPSS Database     http://mpss.udel.edu/at/java.html
 
Table 1:  CDC’s List of Potential Biological Warfare Agents1
 
 
Category A     Category B   
Bacillus anthracis    Brucella species    
Clostridium botulinum toxin   Clostridium perfringens ε-toxin 
Yersinia pestis     Food Safety Threats (i.e. Salmonella  
Variola major (Smallpox)      species, E. coli O157:H7, and Shigella) 
Francisella tularensis    Burkholderia mallei 
Viral Hemorrhagic fevers (i.e. Ebola,  Burkholderia pseudomallei 
   Marburg, Lassa, and Machupo)  Chlamydia psittaci 
        Coxiella burnetii 
        Ricin toxin 
        Staphylococcal enterotoxin B 
        Rickettsia prowazekii 
        Viral encephalitis (i.e. alphaviruses) 
        Water Safety Threats (i.e. Vibrio cholerae, 
           and Cryptosporidium parvum) 
 
* Category C agents include any emerging infectious disease including  
   Nipah virus and hantavirus. 
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Abstract 
Chronic exposure to many heavy metals and metal-derivatives is associated with an 
increased risk of cancer, although the mechanisms of tumorigenesis are largely unknown. 
Approximately 125 scientists attended the 3rd Conference on Molecular Mechanisms of 
Metal Toxicity and Carcinogenesis and presented the latest research concerning these 
mechanisms. Major areas of focus included exposure assessment and biomarker 
identification, roles of ROS and antioxidants in carcinogenesis, mechanisms of metal-
induced DNA damage, metal signaling, and the development of animal models for use in 
metal toxicology studies. Here we highlight some of the research presented, and 
summarize the conference proceedings.  
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Introduction 
The 3rd Conference on Molecular Mechanisms of Metal Toxicity and 
Carcinogenesis was held at the National Institute for Occupational Safety and Health 
(NIOSH) in Morgantown, West Virginia. Over 125 participants from 13 different 
countries gathered at NIOSH to present their research on September 12–15, 2004. This 
conference was the third meeting of metal researchers in the past 5 years, with previous 
conferences convening in 2000 and 2002. Major areas of research emphasized at the 
conference included metal epidemiology, identification of biomarkers, reactive oxygen 
species (ROS) production, antioxidant effects, induction of DNA damage/lesions, metal-
induced signaling pathways, and animal exposure studies. Here, we summarize the 
conference proceedings and examine the future directions of research concerning the 
molecular mechanisms that facilitate metal-induced carcinogenesis. 
 
Epidemiological implications of metal exposure and the search for reliable biomarkers  
Many metals are considered essential trace elements and must be present in low 
concentrations in the human body in order for normal cellular function. However, altered 
concentrations or transition states of metals in the body are thought to lead to a wide 
range of deleterious conditions, especially an increase in cancer incidence. Increased 
metal exposure in humans can occur via ingestion, inhalation, dermal contact, and 
occupational exposure [1–4]. Although correlations between metal exposure and cancer 
are well documented, more research is still needed in order to determine the exact 
mechanisms of metal-induced carcinogenesis. Much of the metal toxicology and 
carcinogenicity data available are acquired in animal model systems, with few studies 
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representing the effects of metals in humans. Therefore, several groups at the conference 
focused their research on the link between the level of metals in the human body and 
carcinogenesis.  Puneet and colleagues presented work examining the role of metals in 
gallbladder carcinoma. Using atomic absorption spectrometry, they showed that the bile 
of gallbladder carcinoma patients contained higher concentrations of cadmium (Cd), 
chromium (Cr), and lead (Pb) than patients with other non-cancerous gallbladder 
diseases, such as gallstones. 
Additionally, Puneet’s group observed an increase in the expression of the metal-
exposure protection protein metallothionein (MT) in 70% of the gallbladder carcinoma 
patients.  These results suggest that the body may concentrate these metals in the 
hepatobiliary system and lead to gallbladder carcinoma. This group also examined the 
lipid peroxidation profiles of gallbladder carcinoma patients in order to determine if a 
free radical-induced mechanism might be involved.  They found a significant increase in 
the amount of a major lipid peroxidation product, 4-hydroxynonenal (4-HNE), in 
gallbladder carcinoma patients compared to patients with other non-cancerous 
gallbladder diseases. These results suggest that the formation of lipid peroxidation 
products in the gallbladder, induced by metal exposure and free radical generation, may 
be an underlying cause of tumorigenesis. 
Many metals must be controlled by a tightly regulated homeostasis. Two such 
examples are copper (Cu) and iron (Fe), the accumulation of which results in oxidative 
stress-induced cellular damage [5, 6]. Wilson’s disease (WD) and primary 
hemochromatosis (PH) are metal storage diseases which are associated with DNA 
damage in the liver. In WD, a defect in a Cu-transporting ATPase results in the 
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intracellular accumulation of Cu [7]. In PH, Fe accumulates in the liver because of a 
mutation in the hfe gene, which is responsible for mediating the effects of the transferrin 
receptor [8]. Patients with both WD and PH are shown to exhibit increased oxidative 
stress-induced etheno-DNA adducts [9]. Vinyl chloride, urethane, and 4-HNE produce 
etheno-DNA adducts as well [10–12]. These adducts can subsequently lead to the 
formation of strong miscoding lesions and cause mutations and/or genomic instability in 
patients suffering from WD and PH.  Nair and Bartsch further examined the correlation 
between the formation of 4-HNE-induced DNA adducts and susceptibility to the 
development of liver cancer. They found that both WD and PH patients exhibiting high 
4-HNE-induced DNA adducts were the most susceptible to the development of liver 
cancer, particularly those patients suffering from PH.  
Conversely, the dietary deficiency of many micronutrients, such as certain trace 
metals, has also been associated with an increased risk of cancer [13–16]. Ansari et al. 
presented data suggesting that significantly lower levels of selenium (Se) and zinc (Zn) 
were found in the serum, biliary fluid, and gallbladder tissue of gallbladder carcinoma 
patients when compared to healthy individuals. Serum manganese (Mn) was also reduced 
in gallbladder carcinoma patients, leading Ansari’s group to conclude that a deficiency in 
these trace elements is also associated with gallbladder carcinoma. 
Since animal studies assessing the effects of metal exposure can often be difficult 
to interpret and inconclusive due to the role of some metals as co-carcinogens, reliable 
biomarkers are needed in order to assess metal exposure in humans. A good candidate for 
a human biomarker must be specific to the effects of the causal agent and easily 
quantitated and/or assayed for its presence in a noninvasive manner. Several studies 
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presented at the conference examined the reliability of biomarkers for metal exposure. 
Using atomic absorption spectrometry, Rahnama et al. analysed the Zn, Cu, Mn, and Fe 
content of saliva and serum from patients with squamous cell carcinoma (SCC) of the 
oral cavity. SCC patients exhibited increased concentrations of Cu, Mn, and Fe in their 
blood and increased concentrations of all four metals examined in saliva when compared 
to healthy individuals. These results suggest that analysis of saliva may be an easy and 
effective way to detect SCC of the oral cavity. 
In order to identify specific biomarkers of mercury (Hg) poisoning Song et al. 
examined cases of peripheral neuropathy in Hg-exposed patients. Levels of selected 
urinary proteins were measured in patients with acute or chronic Hg poisoning and 
healthy control individuals. Elevated levels of the α1-m, β2-m, TRF, IgG, and NAG 
proteins were observed in both acute and chronic Hg-exposed patients, suggesting that 
urine samples may be a simple and inexpensive way to test for Hg exposure. 
In addition to studying the adverse effects of metal exposure, it is important to try 
to develop methods of exposure prevention. For example, Huang’s group attempted to 
develop a correlation model between Fe exposure in coal mines and Coal Workers’ 
Pneumoconiosis (CWP). Fe is an essential trace metal that is stored in Fe-containing 
proteins, such as ferritin and transferrin, where it is tightly bound and unavailable to 
cause oxidative damage [17–19]. Bio-available iron (BAI), such as Fe associated with 
citrate and ATP, has been shown to produce oxidants in a pH-dependent manner [20]. 
Some coal dusts contain BAI, and have been shown to activate the stress-inducible AP-1 
and NFAT transcription factors, while coal dust lacking BAI had no effect on either 
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transcription factor [21]. Previously, BAI content in Pennsylvanian coal was shown to be 
much higher than the BAI content in coal dust originating from Utah [22]. Huang posited 
that BAI content could be used as a predictor of coal toxicity. The BAI content of coal 
from Utah and Pennsylvania was calculated and compared to epidemiological studies 
reporting the incidence of CWP. A significant correlation was found between BAI levels 
and CWP incidence, suggesting that BAI levels may be used to predict the toxicity of 
coal before mining begins. 
A second example of an in vitro predictive model for metal-induced disease was 
introduced by Hockertz et al.  Primary mast cells from human lung tissue and foreskin 
specimens were exposed to wear particle antigens including chromium–cobalt–
molybdenum alloy (CrCoMo), a titanium alloy (TiAL6V4), or ultra-high molecular 
weight polyethylene (UMHWPE), all of which can be released into the human body by 
the degradation of implanted osseoprostheses [23].  Histamine release, indicative of an 
allergic reaction, was observed when the antigens were added to serum-containing media 
and applied to primary mast cells. If a patient’s IgE was present, histamine release 
increased, particularly for the CrCoMo antigen. This in vitro model could be useful in 
preventing potentially dangerous allergic reactions in patients with osseoprostheses and 
reduce the need for the administration of immunosuppressants. 
In some cases, a single biomarker candidate may be difficult to obtain and a 
profiling-based approach may be useful in identifying a molecular fingerprint for toxicant 
exposure. Boyd et al. presented an example of a high throughput strategy utilizing an 
automated robotic workstation (COPAS BIOSORT) to dispense and measure the length 
of Caenorhabditis elegans worms. Toxicological endpoints were examined using a 
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fluorescent dye that only penetrates deceased worms. An imaging workstation was used 
to track the motion of the live worms and acquire multidimensional image analysis data. 
This type of high throughput method can be used to examine the properties of potential 
neurological and developmental toxicants and detect subtle changes in gene or protein 
expression that may be undetectable by conventional methods. 
 
Balancing act: The role of reactive oxygen species (ROS) and antioxidants 
Many transition metals have been shown to produce elevated amounts of 
damaging ROS [24–28]. Disturbing the redox balance of a system leads to an increase in 
DNA damage, DNA-protein crosslink formation, lipid peroxidation, apoptosis, cellular 
toxicity, and/or the inappropriate activation of cellular signaling pathways [29–35]. Since 
the mechanisms of ROS action are not well understood, many conference participants 
focused their studies on the elucidation of these mechanisms. For example, Cr(VI) is a 
transition metal that is known for its ability to produce increased quantities of ROS in 
cellular systems, particularly •OH [36, 37]. Previous studies have focused on the effects 
of soluble Cr(VI), since solubility is thought to be an important factor in its ability to 
contribute to carcinogenesis [38]. However, water insoluble (or particulate) Cr(VI) has 
also been shown to be genotoxic and cytotoxic [24, 39–41].  Leonard et al. examined the 
capability of insoluble Cr(VI) in the form of PbCrO4 to produce ROS using electron spin 
resonance (ESR) spectroscopy and the comet assay. Their results showed that insoluble 
Cr(VI) was capable of producing oxidative stress in a similar pattern to that of soluble 
Cr(VI). 
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Additional studies examining the effects of PbCrO4 in the human lung cell line 
WHTBF-6, were presented by Wise et al. PbCrO4 was shown to enter the lung cells and 
exert clastogenic effects in a dose-dependent manner, although dicentric chromosome 
formation was not observed. In order to exclude Pb ions as the culprits of clastogenicity,  
HTBF-6 cells were also exposed to Pb-glutamate, which yielded no clastogenesis. 
However, Na2CrO4 treatment also proved to be clastogenic in the lung cells, suggesting 
that the CrO42- ions were the cause of clastogenicity. In addition, the antioxidant vitamin 
C prevented the uptake of CrO42- ions and exhibited only a slight effect on Pb levels. The 
cytotoxicity profiles of WHTBF-6 cells exposed to CrO42- ions and PbCrO4 were 
comparable. Both PbCrO4 and Na2CrO4 induced cell cycle arrest and inhibited growth, 
whereas Pb ions alone induced only mitotic arrest. 
ROS production often leads to cell death through cytotoxicity and/or apoptosis, 
prompting several groups to examine the benefits of inducing ROS in a cellular system 
through metal treatment. Farmer et al. used synthetic melanins derived from dihydroxy 
indole (DHI) to study the speciation, metal-binding affinity, and redox reactivity of those 
synthetic melanins. Several metals bound the DHI-melanin, increasing redox cycling and 
the production of •OH and O2•− surprisingly.  Indium(III) ions alone and lipophillic 
metallodithiocarbamate exhibited an unusual amount of toxicity towards melanoma cells 
in culture.  The dithiocarbamate disulfide disulfiram (DSF), which is traditionally 
prescribed as an alcohol-abuse deterrent, also showed strong Cu-dependent activity 
towards melanoma cells. Cen’s group confirmed that DSF exhibited a Cu-dependent 
toxicity towards melanoma cells, whereas nontransformed melanocytes were only 
slightly affected. Upon DSF treatment, melanoma cell survival decreased to less than 
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10% as the intracellular Cu concentrations increased.  The addition of Cu chelators 
blocked the DSF-induced cell toxicity and Cu uptake by melanoma cells. Formation of a 
Cu(deDTC)2 complex was proposed to be the likely active agent. This response is unique 
to Cu(II) and was not observed with Fe(II), Mn(III), or Zn(II), suggesting that local 
administration of Cu and DSF or DHI may be useful in the treatment of melanoma. 
Exposure to metal-containing particulates can also increase ROS production in 
cellular systems. For example, diesel exhaust particles (DEP) have been shown to induce 
DNA adducts and increase inflammation in the respiratory tract [42–46]. DEP contents 
include polycyclic-aromatic hydrocarbons (PAHs), redox active semi-quinones, and trace 
heavy metals [47, 48]. Park et al. compared ROS production of the DEP standard 
reference material 2975 (SRM 2975) and DEP collected from the air in Korea as 
measured by thiobarbituric acid – reactive substances of deoxyribose (TBARS).  
Differences in transition metal composition were observed between samples; DEP from 
Korea contained more Fe, less Cu, and less Zn than SRM 2975. TBARS measurements of 
the water soluble fraction of SRM 2975 showed a broad absorption in the visible range, 
which was absent in the DEP from Korea.  Although SRM 2975 increased the amount of 
TBARS fluorescence, H2O2 generated more TBARS in the DEP from Korea, probably 
due to the increase in Fe composition. These results support a role for Fe in DEP-induced 
H2O2 toxicity, which may be the underlying cause of the adverse health effects of DEP. 
Some substances seem to exert both pro-oxidant and antioxidant effects. Recently, 
many epidemiological and experimental studies have suggested that drinking green or 
black tea may protect against cancer [49, 50]. Sinha et al. presented evidence suggesting 
that tea extracts, in particular the polyphenolic components, exert their 
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chemopreventative effects by acting as antioxidants. They proposed that tea extracts can 
prevent DNA damage caused by sodium arsenite in V-79 Chinese hamster lung 
fibroblasts. However, Azmi et al. presented evidence that the presence of at least one of 
those polyphenolic components, (−) epigallocatechin-3-gallate (EGCG), can induce 
•OH/O2•− formation and increase the rate of DNA oxidation in the presence of Cu ions. 
The results of Azmi’s group suggest that EGCG’s apoptosis-inducing pro-oxidant 
properties may be more important than its preventative antioxidant properties. These 
studies are also supported by the findings of Qanungo et al. and Zykova et al. which 
suggest that tea polyphenols may serve as either an antioxidant or an oxidant, depending 
on the physiological environment [51–53]. 
Ascorbate/ascorbic acid/vitamin C is another compound that has been shown to 
exhibit both pro-oxidant and antioxidant effects [54–58]. Huq and Hussain presented 
evidence suggesting that exposure to Cd acetates increases DNA damage in the presence 
of ascorbate. The mechanism occurs via the formation of a 1:1 covalent Cd(II)/ascorbate 
adduct, causing a molecular activation of the transition metal. This group proposed that 
the deprotonated ascorbate ions bind to 3O2 producing the volatile ROS species, singlet 
molecular oxygen (1O2).  
Ironically, some transition metals may serve as antioxidants and prevent oxidative 
cellular damage. Aravind and Prasad presented evidence that Zn may be able to prevent 
Cd toxicity. Ceratophyllum demersum L. plants were treated with different 
concentrations of CdCl2 and/or ZnCl2. The production of •OH, an oxidative shift in GSH 
levels, loss of carbonic anhydrase conformation, and DNA fragmentation were observed 
with CdCl2 treatment. Upon treatment with both CdCl2 and ZnCl2, the presence of Zn 
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inhibited all of the aforementioned markers of oxidative damage, suggesting that Zn may 
be able to prevent the cytotoxic effects induced by Cd. 
Rhenium is a second transition metal that exhibits low ROS-induced toxicity. 
Thus, cluster rhenium compounds (CRCs) are thought to be a potential drug delivery 
agent. CRCs possess lower toxic effects than other metals currently used as anti-tumour 
agents, including palladium, platinum, and cisplatin [59]. Shtemenko and Shtemenko 
examined the mechanisms of lipid-CRC interactions in solution and during the formation 
of liposomes. They had previously shown that CRCs bind to carboxylic acids, amino 
acids, or adamantanic acids, and subsequently interact with the surface of red blood cells 
to stabilize the membrane in response to free radicals [60]. Administration of CRC1-
dichlorotetra-μ-(i-butirato) dirhenium(III) or CRC2-tetrachlorodi-μ-(γ -aminobutirato) 
dirhenium(III) chloride in models of hemolytic anemia led to an increase in hemoglobin 
and resistance of erythrocytes to oxidative stress, extending the life of hemolytic animals. 
In addition, CRC1 or CRC2 administration increased reduced glutathione pools, 
glutathione reductase expression, and glutathione peroxidase (GPx) expression in the 
tissues of animals with hemolytic anaemia. Thus, CRCs demonstrate antioxidant and 
antiradical properties in vivo and may be useful in the treatment of hemolytic anaemia. 
Cellular systems have developed a wide range of antioxidant mechanimsms to 
combat the dangerous accumulation of ROS. Examples include the increased expression 
of ROS detoxification enzymes, such as catalase and superoxide dismutase (SOD), and 
the maintenance of pools of small molecular ROS scavengers, such as N-acetyl-cysteine 
(NAC) and reduced glutathione (GSH). These ROS scavenging molecules react with 
excess ROS, thus minimizing cellular damage. Glutathione (GSH), although widely 
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known for its antioxidant activity, is also involved in Se metabolism and bioactivity [61]. 
Shen et al. presented evidence that Se caused a dose-dependent onset of mitochondrial 
permeability transition (MPT) in the presence of GSH, which could be inhibited by the 
MPT inhibitor cyclosporin A. An SOD mimic, Mn[III]tetrakis [4-benzoic acid] 
porphyrin, has been previously shown to prevent MPT caused by xanthine (X)–xanthine 
oxidase (XO) [62]. Surprisingly, SOD had no effect on MPT and was unable to prevent 
the reduction of cytochrome c induced by selenite-GSH (Se-GSH) formation. Although 
others have observed an increase in O2•− formation during Se-GSH generation, Shen’s 
group measured O2•− via the lucigenin assay and found no significant increase in O2•−
when compared to O2•− production by the X–XO pathway [63]. These results suggest that 
O2•− is not responsible for Se-GSH-induced MPT in this system. 
Resveratrol is a polyphenolic antioxidant that is synthesized by many plant 
species and has been shown to inhibit the growth of cultured cancer cells [64]. Xia et al. 
presented evidence that ROS-induced activation of the PI3K/Akt survival pathway can be 
inhibited by the presence of resveratrol in prostate cancer cells. Resveratrol also inhibited 
the expression of proteins involved in angiogenesis, such as HIF-1α and VEGF, in a 
dose-dependent manner. Xia’s results suggest that resveratrol may be able to inhibit 
prostate cancer progression and angiogenesis through the inhibition of these pathways. 
 
DNA damage/lesions and mitotic effects 
In addition to producing ROS, many metals have been shown to directly modify 
and/or damage DNA by forming DNA adducts, facilitating DNA protein crosslink 
formation, or inducing chromosomal breaks [33, 44, 65, 66]. Many researchers at the 
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conference presented work reflecting efforts to identify the mechanisms of metal-induced 
DNA damage.  For example, O’Brien et al. examined the role of O2 in Cr(VI)-induced 
DNA lesions and found that hypoxic conditions did not alter Cr(VI) reduction by 
ascorbic acid. However, both Cr(VI)-DNA binding and the occurrence of polymerase 
arresting lesions (PALs) decreased under hypoxic conditions by 70% and 50–90%, 
respectively. These results suggest that O2 can help facilitate the formation of Cr(VI)-
DNA complexes. 
A common oxidative DNA modification, the 7,8-dihydro-8-oxo-2_-
deoxyguanosine (8-oxo-dG) lesion, can lead to the misincorporation of extraneous 
nucleotides during DNA replication [67, 68]. The 8-oxo-dG lesions are prone to further 
oxidation by many transition metals, including Cr(V) and Iridium (IV).  Further oxidation 
of 8-oxo-dG leads to the formation of guanidinohydantoin (Gh) and 
spiroiminodihydantoin (Sp) lesions, subsequently causing G→T and G→ C transversions 
[69, 70]. Gh and Sp lesions are thought to enhance base misincorporation and the 
polymerase blocking effects of the 8-oxo-dG lesion [71, 72]. Certain base excision repair 
(BER) enzymes recognize 8-oxo-dG lesions, but not Gh or Sp lesions [73, 74]. Hailer et 
al. showed that the mammalian BER glycosylases NEIL1 and NEIL2 both recognize and 
cleave Gh and Sp lesions in single-stranded DNA [75].  These results demonstrate that an 
alternative pathway is activated in response to the formation of Gh and Sp DNA lesions. 
The 8-oxo-dG lesion also affects transcription factor binding [76, 77]. Previous studies by 
Sugden’s group reported that binding activity of the NF-κB p50 subunit increases if 
the G1 nucleotide of the NF-κB consensus binding sequence (5’-dAGTTGA 
G1G2G3G4ACTTTCCCAGCC-3’) is replaced with an 8-oxo-dG modified base [77]. In 
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contrast, replacing the G3 nucleotide with an 8-oxo-dG decreases p50 binding activity. 
Sugden et al. found that p50 binding activity to the modified NF-κB consensus sequences 
correlated with p50 in vitro transcription activity, providing a direct link between the 
regulation of gene transcription and ROS formation.  
In addition to inducing DNA lesions, metals can interfere with cellular processes 
such as mitosis. Kligerman et al. presented evidence that arsenicals induced c-type 
anaphases consisting of small, condensed chromosomes – an effect usually seen with 
spindle poisons [78]. They proceeded to investigate the effects of several different 
modified arsenicals on mitosis and found that monomethylarsenous acid (MMAIII) 
exhibited the most potent mitotic interference. When tubulin was directly exposed to 
MMAIII, an increase in the number of mitotic indices (MIs) was observed. None of the 
arsenicals with a valence state of V showed an obvious effect on tubulin polymerization, 
whereas all arsenicals with a valance state of III inhibited tubulin polymerization. Taken 
together, these results indicate that As(III) and its metabolites can interfere with cell 
division. 
Activation of DNA repair enzymes is often observed in response to metal-induced 
DNA damage [79–81]. Lee et al. examined the effects of DNA repair gene 
polymorphisms on the number of Cr(VI)-induced strand breaks in human white blood 
cells. Several DNA repair genes with known genetic polymorphisms were examined, 
including glutathione S transferase M1 (GSTM1), glutathione S transferase T1 (GSTT1), 
NADPH quinine oxidoreductase 1 (NQO1), X-ray repair cross complementation factor 
1 (XRCC1), and the 8-oxo-7,8-dihydroguanine (8-oxo-G) DNA glycosylase (OGG1). 
White blood cells homozygous for the OGG1 Cys326 polymorphism exhibited an 
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increased number of DNA strand breaks when compared to the OGG1 Ser326/Ser326 and 
OGG1 Ser326/Cys326 polymorphisms.  White blood cells homozygous for the OGG1 
Cys326 variation also exhibited an increase in the ratio of oxidative DNA damage to 
plasma antioxidant capacity. These results suggest that OGG1 Cys326 homozygous 
individuals may be defective in the repair of DNA adducts during oxidative stress 
conditions, possibly due to the oxidation of these residues. 
 
Metal-induced cellular signaling 
Although each metal activates its own unique set of signaling events, many metals 
also activate general ROS-mediated stress response pathways. DNA microarray 
technology has recently been used to examine the global effects of metals in several 
model systems. For example, Jin et al. examined the global transcriptional response of 
the yeast Sacchromyces cerevisiae to Zn, Cd, Hg, Cu, silver (Ag), Cr, or arsenic (As) 
exposure. Approximately 25% of the yeast genes were affected by at least one metal (798 
upregulated genes and 774 downregulated genes). Most of the metals upregulated genes 
involved in the oxidative damage process, sulfur assimilation, sulfur metabolism, and 
GSH biosynthesis. Genes encoding biomolecular transporters of sugar and lipid 
metabolism were downregulated. Approximately 10% of the total number of S. cerevisiae 
genes were affected by As treatment – a 2–5-fold increase in the number of genes 
affected by any other metal examined. Additional classes of genes induced by As 
treatment included double-stranded break (DSB) repair and DNA replication genes. 
Other examples of the use of microarray analysis in toxicology studies included 
Song and Freedman’s examination of the global transcriptional effects of Cu treatment on 
 104
a human hepatoma cell line, Hep2G. After 4 h of Cu exposure, 42 genes were 
upregulated and 24 were downregulated. The upregulated genes included metallothionein 
IIA (MT2A), myosin heavy polypeptide (MYH8), CYP1A1, IL-1 receptor alpha 
(IL11RA), heat shock protein A1A (HSPA1A), and heme oxygenase 1 (HO-1). 
Downregulated genes included the HT017 protein, dynamin 1-like (DNM1L), DEAD box 
polypeptide 18 (DDX18), and GST theta 2 (GSTT2).  RT-PCR confirmed the 
upregulation of HSPA1A, CYP1A1, and HO-1 with peak induction levels at 12, 24, and 8 
hours respectively. 
Many of the global effects of metals on transcription are thought to be controlled 
by the interactions between metal response elements (MREs) and MRE binding 
transcription factors such as MTF-1 [82]. Since PKC inhibitors can abrogate MT 
induction, it is thought that some metals induce signaling cascades through PKC 
activation, subsequent alteration of MTF-1 phosphorylation, and activation of MT 
transcription [83]. Craft and Freedman examined the role of p53 activation in MT 
induction by Hg and Cd and found MT transcription was reduced in p53 −/− cells when 
compared to wild-type p53 cells. These results suggest that p53 may be part of a general 
mechanism in the cellular response to both Hg and Cd exposure. 
 
Arsenic signaling 
After a metal ion is transported across the cytoplasmic membrane, its transition 
state is often altered by cellular reducing agents. Reduction of some metals to a lower 
transition state, such as As(V)→As(III), often results in an increase in toxicity; thus it is 
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beneficial to examine the metal’s cellular point of entry. The ArsATPase is a catalytic 
subunit of the Escherichia coli ArsAB pump that translocates As(III) across the cellular 
membrane, conferring resistance to arsenicals and antimonials [84, 85]. There are two 
halves of the Ars ATPase, A1 and A2, each consisting of a nucleotide binding domain 
(NBD) and a metal binding domain (MBD). The NBD and MBD are connected by two 
amino acid linkers which serve as a signal transduction domain [85, 86]. Using site-
directed mutagenesis, Bhattacharjee and Rosen altered residues of the signal transduction 
domain and found that the D142A and P145A mutations caused a loss of As(III) 
resistance. These results indicate that this domain is important in the signaling events 
between the catalytic and allosteric sites of the Ars ATPase. The aquaglyceroporin (AQP) 
family is responsible for the uptake of As(III) and Sb(III) in humans [87, 88]. 
Mukhopadhyay et al. reported that overexpression of human AQP9 in the chronic 
myelogenous leukemia cell line K562 increased uptake of the As(III)-based drug 
Trisenox [89]. Since AQP9 overexpression in K562 cells exhibited hypersensitivity to 
Trisenox, it is possible that pharmacological alteration of AQP9 expression could boost 
Trisenox effectiveness in cancer patients. 
As(III) induces oxidative stress and delays cell cycle reentry into the G1 phase by 
an unknown signaling mechanism [90, 91]. Chen et al. presented evidence that As(III) 
induces ubiquitination and subsequent degradation of the Cdc25C protein, a protein 
which is thought to cause the exit of cells from the G2/M phase [92]. These effects were 
not abrogated by treatment with antioxidants. Furthermore, immunoprecipitation showed 
that Cdc25C associates with the Fzr/Cdh1 recognition subunit of the mitotic APC 
ubiquitin ligase complex. siRNA silencing of Fzr/Cdh1 expression protected Cdc25C 
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from degradation and decreased ubiquitin conjugating activity. Chen’s group concluded 
that As(III) induces the redox-independent ubiquitination and degradation of Cdc25C 
through its association with Fzr/Cdh1.  
As(III) exposure also induces remodelling of the cytoskeleton [93]. Qian et al. 
demonstrated that As(III) activated Cdc42 and NADPH oxidase. Activated NADPH 
oxidase produced O2•− and induced actin filament reorganization in SVEC4-10 cells [94]. 
Overexpression of a dominant negative Cdc42 or treatment with the actin filament 
stabilization agent jasplakinolide inhibited actin filament reorganization and prevented 
NADPH oxidase activation. Qian’s group concluded that As(III) activates NADPH 
oxidase through Cdc42 and leads to actin filament reorganization and the formation of 
lamellipodia and filopodia. These effects could possibly lead to increased cell migration 
and/or metastasis of As(III)-induced tumors. 
Paradoxically, As also exhibits apoptotic-inducing effects. Ivanov and Hei 
presented evidence that human melanoma cells exposed to combinations of low 
concentrations of As (2–10μM) and EGFR, PI3K/Akt, or MEK/Erk inhibitors effectively 
induced apoptosis via the TRAIL and TNFα pathways in spite of low Fas levels [95]. The 
combination of As and synthetic small molecule inhibitors could potentially be used to 
sensitize melanoma cells to cytotoxic drugs, enabling the development of more effective 
chemotherapy regimens. 
Lemarie et al. further examined the apoptotic pathway induced by As and found 
that As2O3 prevented monocyte adhesion and expression of the macrophage phenotypical 
markers transferrin receptor CD71 and integrin CDIIc. As2O3 induced monocyte 
apoptosis, increased caspase 8 and caspase 3 expression, decreased cFLIP and XIAP 
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expression, decreased NFκB binding activity, and exhibited a loss of mitochondrial 
membrane potential. Lemarie’s group suggested that As2O3 may induce apoptosis by 
inhibiting NFκB activity and subsequently decreasing the expression of the cFLIP and 
XIAP pro-survival proteins, both of which are transcriptionally controlled by NFκB. 
Taken together, these studies may provide insight into the signaling pathways responsible 
for As’s ability to induce apoptotic effects as well as carcinogenic effects. 
 
Chromium signaling 
Cr(VI) has been known to produce ROS, induce DNA damage, and subsequently 
activate the ATM, p53, and Chk2 proteins [96, 97]. It is known that ATM is activated 
specifically in response to DSBs, however no Cr-induced DSBs have been reported [98–
101]. Ceryak et al. exposed normal human dermal fibroblasts to Cr(VI) or the 
radiomimetic agent neocarzinostatin (NCS) and analysed the occurrence of DSBs, the 
phosphorylation status of histone H2A.X (γ -H2AX), and the formation of γ -H2AX 
nuclear foci. Their evidence suggested that DSBs were formed in response to Cr(VI) 
exposure in an S phase-dependent manner, while NCS exposure exhibited an equal 
distribution of DSB formation throughout all phases of the cell cycle. Additionally, 
Cr(VI) exposure showed γ -H2AX foci formation in PCNA positive cells; an effect that 
was absent in the NCS-exposed control cells and decreased in ATM−/− cells. 
Xie et al. independently showed that PbCrO4 induced DSBs in a dose-dependent 
manner, resulting in the activation of ATM in human lung cells. γ -H2AX is rapidly 
phosphorylated on Ser139 when DSBs are induced by ionizing radiation [102]. Xie’s 
group also showed that PbCrO4 induced a concentration-dependent phosphorylation of γ -
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H2AX and subsequent foci formation. Taken together, these results demonstrate a 
general mechanism for Cr(VI)-induced carcinogenesis involving the induction of S 
phase-dependent DSBs and marked by γ -H2AX foci formation. 
Xu presented additional evidence that Cr(VI) exposure activates ATM/ATR, 
phosphorylates the structural maintenance chromosome 1 (SMC1) protein, and activates 
caffeine sensitive S phase cell cycle arrest in a dose-dependent manner.  Surprisingly, 
Cr(VI)-induced S phase cell cycle arrest was shown to be independent of ATM at high 
concentrations. Xu proceeded to examine alternate pathways responsible for Cr(VI)-
induced S phase cell cycle arrest and found that Rad17, which is required for the release 
of active ATR, bound the site of Cr(VI)-induced DNA damage. A non-functional Rad17 
showed impaired S phase arrest in response to Cr(VI) exposure, suggesting that a low 
dose of Cr(VI) activates an ATM-dependent pathway, whereas a high dose of Cr(VI) 
activates an ATR-dependent pathway. 
 
Cadmium signaling 
The activation of transcription factors by metals is one of the most commonly 
studied effects of metal-induced cellular signaling. However, recent interest has been 
expressed in alternative targets of metal signaling, such as the translational machinery 
pathways. Aberrant regulation of the expression of the translational control proteins eIF3 
and eEF1δ has been shown to be responsible for Cd(II)-induced transformation and 
tumorigenesis [103, 104]. Orthumpangat et al. presented evidence that a third 
translational control protein may also affect the cellular response to metals. Cell lines 
exposed to Cd(II) exhibited a decrease in eIF4E protein expression. siRNA silencing of 
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eIF4E induced cell death, whereas eIF4E overexpression resulted in cell survival after 
exposure to an otherwise lethal dose of Cd(II). Cd(II) exposure also activated the 
ubiquitin pathway, resulting in the degradation of eIF4E and a subsequent decrease in 
cyclin D1 expression.  
The expression of other members of the translational machinery family were 
altered upon exposure to Cd(II). One such protein, eEF1A2 is a cellular proto-oncogene 
which is overexpressed in many cancer cell lines and tumors. Orthumpangat’s group 
reported that eEF1A2 expression was increased in response to Cd(II), while 
overexpression of eEF1A2 conferred resistance to Cd(II)-induced apoptosis. These 
results confirm that the translational machinery is a potential mechanism for Cd(II)-
induced carcinogenesis.  
Hep3B human hepatocarcinoma cells have been shown to undergo Cd-induced 
apoptosis in a caspase-independent manner [105]. The mechanism is thought to involve 
the nuclear translocation of endonuclease G (endoG) and the apoptosis-inducing factor 
(AIF), both of which are mitochondrial apoptogenic proteins. Lemarie et al. showed that 
the release of endoG and AIF in response to Cd exposure was preceded by an increase in 
cytoplasmic Ca2+ and a loss of mitochondrial membrane potential. Bapta-AM, a Ca2+ 
chelator, blocked these events and prevented apoptosis. Inhibition of ROS production by 
the mitochondrial inhibitors ruthenium red, rotenone, and diphenyleneiodonium 
prevented the loss of mitochondrial membrane potential. Bapta-AM and 
diphenyleneiodonium also blocked expression of the NFκB-regulated anti-apoptotic 
protein bcl-x(L) in Cd exposed cells. Lemarie’s group concluded that Cd induces 
apoptosis in Hep3B cells through Ca2+ release and ROS-induced impairment of the 
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mitochondria. These results are in agreement with the hypothesis that Cd-induced 
apoptosis occurs through the release of endoG and AIF. 
 
Cobalt and copper signaling 
Exposure to the hard metal dust tungsten carbide–cobalt mixture (WC–Co) 
directly correlates with an increased risk of  cancer in exposed workers [106]. Lombaert 
et al. demonstrated that both cobalt (Co) and WC–Co induced apoptosis of peripheral 
blood mononucleated cells (PBMCs). WC–Co apoptosis occurred at a higher rate than 
Co-induced apoptosis and was dependent on caspase 9 activation, whereas Co-induced 
apoptosis depended on the activation of both caspases 8 and 9. These results demonstrate 
that although WC–Co and Co can produce similar cellular effects, the signaling 
mechanisms may be different.  
Although Cu is a trace element necessary for the function of enzymes such as 
SOD, it can also produce ROS, DNA damage, and other carcinogenic effects when 
present in excess. Cherian and Ostrakhovitch examined the effects of Cu exposure on the 
p53 tumour suppressor signaling pathways in the breast cancer epithelial cell lines MDA-
MB-231 and MCF7. p53 mutant MDA-MB-231 cells are resistant to metal toxicity, while 
p53 wild-type MCF7 cells are sensitive to metal-induced apoptosis [107, 108]. ROS 
production was not observed in MDA-MB-231 cells exposed to Cu; however, an increase 
in Akt phosphorylation, Akt nuclear translocation, Cyclin D1 expression, and cell cycle 
progression were still apparent. In contrast, ROS production in MCF7 cells increased in 
response to Cu exposure. Increases in p53 expression, p21 expression, G1 phase arrest, 
and apoptosis in MCF7 cells were also observed. Additionally, Cu-exposed MCF7 cells 
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exhibited a loss of mitochondrial membrane potential and lacked Akt activation and 
translocation. Suppression of p53 in MCF7 cells with pifithrin or E6 protein decreased 
p53 phosphorylation and increased Akt phosphorylation, suggesting that p53 is involved 
in the response to Cu-induced ROS formation [109]. 
 
Nickel signaling 
Insoluble nickel (Ni) compounds, such as Ni3S2, green NiO, black NiO, and Ni 
refinery dust, have been shown to exert carcinogenic effects in a variety of animal 
experiments [110]. Landolph et al. showed that Ni3S2, green NiO, and black NiO are 
phagocytosed by C3H/10T1/2 mouse embryo cells. Cytotoxicity, chromosomal 
aberrations, and morphological transformation were observed upon Ni exposure. The 
extent of phagocytosis was shown to correlate with each Ni compound’s ability to induce 
transformation. RAP-PCR differential display experiments showed 130 genes that were 
differentially expressed between the Ni-transformed and nontransformed cell lines. 
Increased expression of the ect-2, calnexin, and wdr1 genes in transformed cells were 
confirmed by Western blot. Respectively, these genes encode a Rho GDP/GTP exchange 
factor that modulates microtubule assembly, a molecular chaperone, and a stress-
inducible protein. Decreased expression of the vitamin D receptor interacting 
protein/thyroid hormone activating protein 80 (DRIP/TRAP-80) and two other novel 
genes was also observed in transformed cells. Landolph’s group concluded that Ni ions 
generate ROS, mutate and activate proto-oncogenes and/or tumour suppressor genes, and 
also induce chromosomal aberrations. 
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Paradoxically, Ni can upregulate the expression of some genes while 
downregulating others, possibly through the post-translational modification of histones. 
Ni suppresses the acetylation of core histones H3 and H4 and induces de novo DNA 
methylation, leading to gene silencing [34,111]. Costa’s group found that water-soluble 
Ni salts could inhibit the acetylation of the core histones H2A, H2B, H3, and H4. Ni 
exposure also induced methylation of Lys 9 in histone H3 and increased the 
ubiquitination of histones H2A and H2B. Golebiowski and Kasprzak also examined the 
acetylation status of the N-terminal tails of the core histones in Ni-exposed human and 
rodent cells exposed to Ni(II). Histone H2B exhibited the least acetylation, followed by 
histones H4, H3, and H2A in human airway epithelial cells and normal rat kidney cells. 
However, these effects were not seen in Chinese hamster ovary (CHO) cells, suggesting 
that the decrease in acetylation may be cell-type dependent.  Ni(II) has been shown to 
cleave the –SHHKAKGK motif of the C-terminal tail of histone H2A in vitro and in cell 
culture [112, 113]. Karaczyn et al. examined the effects of Ni(II) on other histones and 
showed that histone H2B abundance increases with Ni(II) treatment over time. Mass 
spectrometry and amino acid sequencing analysis confirmed that the H2B 
immunoreactive bands were variants of histone H2B. The larger band represented a 
truncated histone H2B lacking 16 amino acids from the N-terminal tail. The smaller band 
represented a histone H2B variant lacking both the 16 N-terminal amino acids and an 
additional nine amino acids from the C-terminal tail. Post-translational modifications of 
the smaller band included two acetylated Lys residues. Similar, but weaker effects on 
histone H2B were seen with Co(II), but no effects were seen with Cu(II), Cd(II), or 
Zn(II). Since the terminal tails of histones are thought to play key roles in structuring 
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chromatin and regulating gene expression, the loss of these regions may be involved in 
the mechanisms relating to Ni(II)-induced carcinogenesis. Taken together, these results 
suggest that histone modification may play a major role in the mechanism of Ni-induced 
gene activation and/or silencing. 
In addition to modifying core histones, Ni-exposure also activates the HIF-1α 
transcription factor via the depletion of intracellular Fe and the subsequent inhibition of 
the Fe-dependent enzyme proline hydroxylase, which leads to the stabilization of HIF-1α 
[114]. Huang et al. examined the effects of Ni3S2 or NiCl2 exposure on other transcription 
factors and found that Ni ions increased ROS production and activated NFAT. NFAT 
activation was inhibited by catalase, NAC, and desferoxamine (DFO), but not by SOD or 
sodium formate. Ni activation of the HIF-1α, PI3K, Akt, and p70S6K 
was abrogated by PI3K inhibitors. Overexpression of Akt and PI3K dominant negative 
(DN) mutants also inhibited HIF-1α activation and Cap43 expression, while exposure to 
rapamycin, a p70S6K inhibitor, had no effect. In conclusion, Huang’s group suggested 
that Ni generates H2O2 which in turn activates NFAT. HIF-1α and Cap43 are also 
activated by Ni via a PI3K/Akt-dependent pathway, independently of p70S6K activity. 
 
Animal studies 
Although animal studies provide valuable information concerning the toxic 
effects and signaling pathways of environmental contaminants, adequate animal models 
do not exist for some metals due in part to their roles as co-carcinogens. Thus, it is 
difficult to assess the effects of the metal itself because a known carcinogenic compound 
must be administered simultaneously in order for a tumour to develop. For example, 
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Burns et al. presented evidence that hairless mice (Skh1strain) exposed to ultra-violet 
radiation (UVR) and Cr- or As-contaminated drinking water elevated the number of 
tumors produced by UVR to 8.3- and 4.6-fold, respectively. These data confirm that 
metals can act as hazardous co-carcinogens even at low levels of exposure. 
Most metal toxicity studies have been conducted on adult animals, yet few have 
focused on the effects of metal exposure during the pubescent period. Chatterjee et al. 
examined Sprague–Dawley rats exposed to intravenous-infused CdCl2 40–100 days after 
birth. Histopathological examination of the mammary tissue showed that Cd(II) exposure 
slightly suppressed apoptosis while DNA strand breaks increased by 61%. At low doses, 
no change in histopathology of the mammary tissue was observed. However, at high 
doses, exposed rats exhibited intraductal proliferations. In addition, MT expression was 
elevated 60–86% in Cd(II)-treated animals in a dose-dependent manner. These results 
indicate that Cd(II) exposure may lead to an increased incidence of cancer in pubescent 
animals. 
Additionally, Chatterjee et al. examined the chemopreventive effects of vanadium 
(V) supplementation. Rats were exposed to diethlnitrosamine (DEN) and phenobarbitol 
to induce hepatocarcinogenesis, and subsequently fed V-supplemented chow for 20 
weeks. V supplementation reduced the nodular incidence, total number of tumors, and 
multiplicity of tumors, and decreased metallothionein expression, BrdU labelling index (a 
marker of cell proliferation), and iNOS expression. In addition, V supplementation 
increased p53 immunoreactivity and the apoptotic labeling index. These results suggest 
that V may play a significant role in controlling cellular activities during chemical-
induced hepatocarcinogenesis.  
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Depleted uranium (DU) is a radioactive heavy metal used to manufacture military 
munitions. United States military personnel wounded by DU shrapnel may have a higher 
risk of cancer incidence, due to DU’s genotoxic and mutagenic effects [115, 116].  DU 
can also cause radiation-specific cellular damage and transformation of human osteoblast 
cells [117, 118]. In order to simulate the effects of a DU-containing shrapnel wound, 
Miller et al. implanted non-tumourigenic immortalized cells into syngenic DBA/2 mice 
with or without DU implantation pellets. Mice implanted with DU pellets showed an 80% 
incidence of tumorigenesis, whereas control mice exhibited a 10% incidence of leukemia, 
suggesting that DU can significantly enhance tumour incidence. 
Chromium(III) Picolinate (Cr(Pic)3) is a dietary supplement associated with 
oxidative damage, DNA damage, antioxidant enzyme depletion, and renal/liver 
dysfunction in rats [119, 120]. In cell culture, Cr(Pic)3 has been shown to cause mutations 
and DNA fragmentation [121]. Rasco et al. examined the prenatal effects of dietary 
supplementation of Cr(Pic)3, CrCl3, or picolinic acid in pregnant female mice. The 
fetuses birthed from the Cr(Pic)3-fed females showed an increase in bifurcated cervical 
arches, delays in righting reflex, delays in hind limb grasp, and deficiencies in motor 
skills. These results demonstrate that dietary supplementation of Cr(Pic)3 exerts negative 
effects on the developing nervous system of mammalian fetuses.  
Barchowsky et al. developed an animal model to examine the effects of As(III) on 
angiogenesis and the expression of tissue remodelling genes in cardiac tissue. Male mice 
were exposed to As(III)-contaminated drinking water at low to moderately high 
concentrations for up to 20 weeks. Enhanced vascularization of Matrigel implants was 
observed after 5 weeks of As(III) exposure. RT-PCR showed a dose and time-dependent 
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induction of VEGF, VEGF receptors, plasminogen activator inhibitor-1, endothelin-1, 
and matrix metalloproteinase-9 in cardiac tissue. Barchowsky’s group concluded that the 
effects of chronic As(III) exposure on the cardiovascular tissue varies with dose and 
length of exposure. 
 
Summary 
The research presented at the 3rd Conference on Molecular Mechanisms of Metal 
Toxicity and Carcinogenesis provided new insights into the mechanisms of ROS 
production, the mechanisms of metal signaling, and the development of animal exposure 
models. However, the following areas of metal research still need further exploration. 
First, there is a need for the development of new human biomarkers for metal exposure. 
Without definitive and specific biomarkers, it is very difficult to assess the extent of 
metal exposure in humans, and thus, difficult to treat the resulting ailments. Second, since 
most metals cause some form of ROS-induced cellular stress, the elucidation of the 
mechanisms of ROS production may provide information concerning the general 
mechanisms of metal-induced carcinogenesis. Third, defining the mechanisms of metal-
induced DNA damage may provide new insights into the signaling events involved in 
DNA damage repair pathways. Fourth, a better understanding of the complex signaling 
networks that lead to the adverse effects of metals could lead to the identification of 
superior and more specific novel therapeutic agents. Finally, better animal models for 
metal exposure are necessary in order to thoroughly evaluate the toxic and carcinogenic 
effects of metals in a model system. Through the use of current technology and the 
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As(III) transcriptionally activates the gadd45a gene via the 
formation of H2O2 
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ABSTRACT:   
Arsenic is a ubiquitous environmental contaminant associated with an increased risk of 
human cancers of the skin, lung, bladder, and prostate.  Intriguingly, it is also used to 
treat certain types of leukemia.  It has recently been suggested that these paradoxic 
effects may be mediated by arsenic’s ability to simultaneously activate DNA damage, 
apoptotic, and transformation pathways.  Here, we investigate the effects of arsenic 
exposure on the induction of the growth arrest and DNA damage protein 45α 
(GADD45α), which is thought to play roles in apoptosis, DNA damage response, and cell 
cycle arrest.  We found that arsenic transcriptionally activates the gadd45α promoter 
located in a 153 base pair region between -234 and -81, relative to the transcriptional start 
site.  In addition, this transcriptional induction was abrogated in the presence of H2O2 
scavengers, suggesting a role for H2O2 in the transcriptional control of the gadd45a gene 





Inorganic arsenic is a ubiquitous environmental contaminant associated with a 
multitude of adverse health effects, including hyperkeratosis, hyperpigementation, 
diabetes mellitus, cardiovascular disease, reproductive defects, and cancers of several 
tissues including liver, bladder, skin, lung, kidney, and prostate [1-17].  The most 
common route of arsenic exposure is the ingestion of contaminated drinking water, which 
has been documented in many countries at concentrations as high as 3.4 mg/L; more than 
3000 times the World Health Organization recommended limits of 10 μg/L [18-23].  In 
the United States, more than 56 million Americans are estimated to have been exposed to 
drinking water containing arsenic concentrations that elevate the fatal cancer risk [24]. 
 Although arsenic is poorly mutagenic in rodent and bacterial models, it has been 
shown to cause DNA adduct formation, DNA-protein crosslinking, and the formation of 
reactive oxygen species (ROS) in vitro [25-27].  In addition, arsenic has been shown to 
induce an assortment of signaling events including NF-κB activation, AP-1 activation, c-
myc overexpression, involucrin repression, and extracellular signal-regulated kinase 
(ERK) activation, which are involved in such diverse processes as DNA repair, cellular 
differentiation, cell cycle arrest, and malignant transformation [28-32].  Together, these 
findings suggest that arsenic may be exerting its carcinogenic effects through an 
epigenetic mechanism. 
 Cell cycle dysregulation and/or perturbation is a major mechanism of 
carcinogenesis.  While the signaling pathways involved in the G1/S phase checkpoint 
have been well examined, much less is known about the signaling events that occur at the 
G2/M phase checkpoint.  Previous data from our lab and others have suggested that 
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arsenic treatment can induce G2/M phase growth arrest in several different cell lines [33-
36].  A major player in G2/M arrest is the growth arrest and DNA damage-inducible 
protein 45α (GADD45α), which is induced by  a variety of stress-induced signals 
including methyl methanesulfonate (MMS), ultraviolet (UV) irradiation, ionizing 
radiation (IR), sodium arsenite exposure, and serum starvation [37-42].  In addition, 
GADD45α is proposed to play roles in chromatin remodeling and apoptosis [43,44].  
Transcription of the gadd45a gene is thought to be controlled by both the 
promoter region and the third intron region and seems to be differentially activated 
depending on the stimulus [45].  For example, in response to IR, the p53 transcription 
factor binds to its consensus sequence site in the third intron of the gadd45a gene and 
subsequently interacts with the WT1 transcription factor to enhance gene expression [46].  
However, several groups have also suggested that after MMS and UV exposure, the 
ubiquitous Oct-1 transcription factor binds the promoter region between -101 and -82 
base pairs (bp) relative to the transcriptional start site (tss) of the gadd45a gene with the 
help of an unidentified cofactor to activate gadd45a transcription in a p53-independent 
manner [47-50].  Recently, the forkhead transcription factor family member FOXO3a, 
has also been shown to bind to the forkhead response elements (FHREs) located in the 
gadd45a gene promoter region at -505, -377, and -803 in response to UV, resulting in 
transcriptional activation [51].  Thus, gadd45a gene regulation is complex and may 
involve many different signaling pathways. 
 Since GADD45α is a general stress response protein, we examined the effects of 
ROS produced in response to As(III) exposure on gadd45a gene regulation.  We used a 
human bronchial epithelial airway cell line, BEAS-2B, to examine these effects because 
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the lung is a target of arsenic induced carcinogenesis, particularly in occupational settings 
[7].  Our results show that As(III) transcriptionally induces gadd45a gene expression 
from its promoter region via a free radical mechanism involving the formation of H2O2. 
 
Materials and Methods 
Cell Culture and Media.   
The BEAS-2B human lung epithelial cell line was obtained from the American Type 
Culture Collection (Manasses, VA) and maintained in Dulbecco’s Modified Eagle 
Medium (Sigma, St. Louis, MO) containing 5% fetal bovine serum (Invitrogen/Gibco 
BRL, Carlsbad, CA), 1 unit/mL penicillin, 1 μg/mL streptomycin, and 300 μg/mL L-
glutamine (Sigma, St. Louis, MO).  BEAS-2B cells were passaged when confluency was 
reached, usually every 4-5 days. 
 
Western Blotting.  
Six well tissue culture plates were grown to a density of approximately 1 x 106 cells per 
well and treated with concentrations of AsCl3 (Sigma, St. Louis, MO) ranging from 0-50 
μM over a time period of 0-24 hours.  Phosphate buffered saline (PBS) washed cells were 
incubated five minutes with 100 μL of MPER mammalian lysis reagent (Pierce 
Biotechnology, Inc., Rockford, IL) with shaking at room temperature.  A portion of each 
sample’s cell lysate (25 μL) was subsequently analyzed for total protein concentration 
using a BCA Protein Assay kit (Pierce Biotechnology, Inc., Rockford, IL).  Pre-cast 4-
20% gradient polyacrylamide gels (Invitrogen, Carlsbad, CA) were loaded with 20 μg of 
total protein for each sample and electrophoresis was perfomed for approximately 105 
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minutes at 125 volts using a 1X dilution of  10X Tris-Glycine Running Buffer 
(Invitrogen, Carlsbad, CA), the XCell SureLock Mini-Cell system (Invitrogen, Carlsbad, 
CA), and a PowerPac 300 power supply (Bio-Rad Laboratories, Hercules, CA).  Gels 
were rinsed with a 1X dilution of 25X Tris-Glycine Transfer Buffer (Invitrogen, 
Carlsbad, CA) and transferred to a PVDF membrane (Invitrogen, Carlsbad, CA) at 35 
volts for two hours using the XCell II Blot Module (Invitrogen, Carlsbad, CA).  PVDF 
membranes were blocked for 1 hour at room temperature with 5% milk buffer in TBS-
Tween (Sigma, St. Louis, MO).  Membranes were incubated with a 1:200 dilution of 
GADD45α (H-165) primary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) 
in 5% milk buffer overnight at 4º C on a rocking platform. For β-actin primary antibody 
(Sigma, St. Louis, MO) and GAPDH primary antibody (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA), dilutions of 1:2000 and 1:200 were used, respectively.  Membranes 
were subjected to three ten minute washes with TBS-Tween (Sigma, St. Louis, MO) and 
immediately placed in a 1:1000 dilution of an anti-rabbit or anti-mouse IgG AP-linked 
secondary antibody (Cell Signaling Technology, Beverly, MA) in 5% milk buffer for 2-4 
hours at room temperature with shaking.  After three ten minute washes with TBS-Tween 
(Sigma, St. Louis, MO), membranes were immediately incubated with CDP-Star Reagent 
(New England BioLabs, Inc., Beverly, MA) for five minutes with shaking in the dark at 
room temperature. Membranes were rinsed with TBS-Tween and exposed to X-ray film 
(Daigger, Vernon Hills, IL).  
 
Oxygen Consumption.   
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A Gilson 5/6 Oxygraph (Gilson Medical Electronics, Inc.,  Middleton, WI) was used to 
perform oxygen consumption studies.  BEAS-2B cells were trypsinized and washed with 
1X PBS (Invivtrogen/Gibco BRL, Carlsbad, CA) and 4 x 106 cells were re-suspended in a 
final volume of 1 mL of PBS.   1mM AsCl3 (Sigma, St. Louis, MO) was added to each 
aliquot and allowed to incubate for 20 minutes at room temperature.  Oxygen 
consumption rates were calculated using the following equation: 
 
nmoles O2 consumed/minute/106 cells = (BP – 47) ΔB (1.835) , 
      (m)(t)(n) 
 
where BP = atmospheric pressure in mmHg,  ΔB = number of vertical blocks traversed 
on the oxygraph chart paper (rise of experimental slope), m = slope of O2 standards (409 
in this case), t = time in minutes used to determine ΔB (run of experimental slope), and n 
= n x 106 cells used in the assay.  Three replicates of three different samples were 
averaged together to determine mean O2 consumption and error bars equal ± standard 
error of the mean (SEM). 
 
Electron Spin Resonance (ESR).   
1 x 106 BEAS-2B cells were suspended in 500 μL of 1X PBS (Invitrogen/Gibco BRL, 
Carlsbad, CA) and treated with 1 mM AsCl3 (Sigma, St. Louis, MO) and/or 2000 U/mL 
catalase isolated from bovine liver (Sigma, St. Louis, MO).  All ESR measurements were 
conducted using a Bruker EMX spectrometer (Bruker Instruments Inc. Billerica, MA) 
and a flat cell assembly.  Hyperfine couplings were measured (to 0.1 G) directly from 
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magnetic field separation using potassium tetraperoxochromate (K3CrO8) and 1,1-
diphenyl-2-picrylhydrazyl (DPPH) as reference standards.  The relative radical 
concentration was estimated by multiplying half of the peak height by (ΔHpp)2, where 
ΔHpp represents peak-to peak width. The Acquisit program was used for data acquisitions 
and analyses.  Reactants were mixed in test tubes in a final volume of 1.0 mL.   The 
reaction mixture was then transferred to a flat cell for ESR measurement.  The 
concentrations given in the figure legends are final concentrations.  Experiments were 
performed at room temperature and under ambient air.  Statistical analysis was performed 
using Student’s t-test and error bars equal ± SEM. 
 
Construction of GPx1-EGFP and SOD1-EGFP fusion constructs.   
pcDNA3.1(+)/GPx1 and pcDNA3/SOD1 constructs were graciously provided to our 
laboratory by Dr. Larry Oberley’s lab at the University of Iowa [52,53].  The GPx1 
cDNA was removed from the pcDNA3.1 construct using a BamHI (Promega Life 
Sciences, Madison, WI) and HindIII (Promega Life Sciences, Madison, WI) double 
enzymatic digest.  The SOD1 cDNA was removed from the pcDNA3 constuct using a 
KpnI (Promega Life Sciences, Madison, WI) and ApaI (Promega Life Sciences, Madison, 
WI) double enzymatic digest.  Both GPx1 and SOD1 cDNA fragments were isolated 
from an agarose gel and ligated into a pEGFP-C3 (BD Biosciences – Clontech, Palo Alto, 
CA) vector in frame with the EGFP protein.  Contents of both vectors were verified by 
DNA sequencing (Biotech Core, Inc., Mountain View, CA).  
 
Transient transfections.  
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Transient transfections were performed using SuperFect Transfection Reagent (Qiagen, 
Inc., Valencia, CA) according to the manufacturer’s instructions.  Briefly, cells were 
plated at 50% confluency, and DNA/SuperFect complexes were allowed to enter BEAS-
2B cells for three hours.  DNA complexes were removed and fresh growth medium was 
added.  Transfection efficiencies of the pEGFP-C3, pEGFP-C3/GPx1, and pEGFP-
C3/SOD1 were calculated by counting EGFP (+) cells with a confocal microscope and 
determined to be roughly 8-10% for all three plasmids. 
 
Quantitative real- time polymerase chain reaction (qRT-PCR).   
Total RNA was isolated from approximately 1 x 106 BEAS-2B cells using an RNeasy 
Mini Kit (Qiagen, Inc., Valencia, CA).  Total RNA was quantified using a NanoDrop 
ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE).  
Quantitect SYBR Green one-step qRT-PCR kits (Qiagen, Inc., Valencia, CA) were used 
to set up qRT-PCR reactions using 10 ng of total RNA as a template.  qRT-PCR 
experiments were performed on an ABI 7700 qRT-PCR machine (Applied Biosystems, 
Foster City, CA).  Validated GADD45α primer sets were obtained from Qiagen, Inc.  
(Valencia, CA) and 18S rRNA primer set controls were obtained from Ambion, Inc. 
(Austin, TX).  Each sample was replicated three times per plate and an average ΔCt value 
was calculated.  Relative quantitation of GADD45α mRNA was calculated using the 
ΔΔCt method.  Error bars represent ± SEM. 
 
Dual-Luciferase Reporter Assay.   
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BEAS-2B cells were applied to 12-well tissue culture plates at approximately 50% 
confluency and transiently transfected with either a full length or deleted GADD45α 
promoter-firefly luciferase construct (kind gifts from Dr. Dennis Bruemmer at the 
University of California – Los Angeles, CA) or a GADD45α intron 3- firefly luciferase 
construct (a kind gift from Dr. Albert J. Fornace, Jr. at Harvard University, Cambridge, 
MA) [54,55].  In addition, each sample was co-transfected with a pRL-TK Renilla 
luciferase vector (Promega Life Sciences, Madison, WI) underneath the constitutive 
control of the herpes simplex virus thymidine kinase promoter to provide a measure of 
transfection efficiency for normalization.  Constructs were allowed to express for at least 
60 hours followed by a 12 hour treatment with 25 μM AsCl3 (Sigma, St. Louis, MO).  
100 μL of firefly luciferase substrate was injected into each well of a Lumitrac 200 96-
well plate (USA Scientific, Inc., Ocala, FL) containing 20 μL of cell lysate.  Firefly 
luciferase units were measured by an EG&G Berthold Microplate Luminometer 
MicroLumat Plus with an automatic injector (EG&G Berthold, Germany).  WinGlow 
software (EG&G Berthold, Germany) was used to obtain readings with a 2.0 second 
delay and a 10.0 second measurement of luciferase activity and expressed in luciferase 
units.  Luciferase substrates were obtained from the Dual-Luciferase Reporter Assay kit 
(Promega Life Sciences, Madison, WI).  Three replicates were assayed per experiment 
and the ratio of inducible firefly luciferase activity to basal Renilla luciferase activity was 
averaged for each group.  Fold induction was calculated by dividing the average ratios of 
As(III)-treated samples by the average ratios of samples left untreated.  Error bars 
represent ± SEM and statistical significance was calculated using Student’s t-test.  Data 




As(III) exposure induces expression of the GADD45α  protein in a time- and  dose-
dependent manner.  Because GADD45α expression has been observed in response to 
many stress conditions including UV irradiation, serum starvation, and alkylating agents, 
we investigated the effects of As(III) exposure on its induction [32,37,38]. In order to 
simulate airway exposure to arsenic, an immortalized non-tumorigenic BEAS-2B human 
lung airway epithelial cell line was used for these experiments.  Western blot analysis of 
GADD45α in response to increasing concentrations of AsCl3 revealed a time- and dose-
dependent increase in protein abundance (Fig. 1), whereas equal concentrations of NaCl 
had no effect (data not shown).  β-actin abundance remained unaffected throughout the 
dose and time course of As(III) exposure.  Densitometry readings, normalized to β-actin 
expression, confirmed that GADD45α protein abundance increased more than 100-fold 
over untreated BEAS-2B cells 12 hours after 25 μM As(III ) treatment (data not shown).  
This result demonstrates that GADD45α protein is induced in BEAS-2B cells in response 
to As(III) exposure in a dose-dependent manner. 
 
As(III) exposure increases oxygen consumption and ˙OH production  in BEAS-2B 
cells.  Since As(III) has been shown to exert mutagenic effects via reactive oxygen 
species (ROS) production in several cellular systems, it is possible that the signaling 
events induced by As(III), specifically GADD45α induction, are also mediated by a ROS 
mechanism [56].  In order to address this possibility, BEAS-2B cells were exposed to 1 
mM As(III) for 20 minutes and the rate of oxygen consumption was measured by a 
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Gilson 5/6 Oxygraph.  As(III)-exposed BEAS-2B cells showed approximately a three-
fold increase in the amount of oxygen consumed in vitro (Fig. 2A), suggesting that a free 
radical mechanism may be occurring in BEAS-2B cells upon As(III) stimulation.   
 To determine the identity of the radicals produced, we employed electron spin 
resonance (ESR) spectroscopy.  Representative ESR spectra are displayed in Figure 2B.  
A basal level of ˙OH, signified by its 1-2-2-1 relative peak height fingerprint, is produced 
by normal BEAS-2B cells, and was expected as a consequence of normal respiration;  
however, after a 20 minute exposure to 1mM As(III), the ˙OH signal significantly 
increased (Fig. 2B).  Spectral results were quantified by peak height measurements in 
Figure 2C, where a 2.5- fold increase in ˙OH production was observed after As(III) 
exposure when compared to normal respiring cells.  The ˙OH signal was attenuated by 
the addition of 2000 units/mL of catalase, showing that H2O2 is a precursor of ˙OH.  
These data indicate that ˙OH is a major free radical formed in the BEAS-2B cell line in 
response to As(III) exposure. 
 
GADD45α  protein abundance decreases  in response to As(III) in the presence of the 
H2O2  scavenger, GPx1.  Because As(III) produced ˙OH in the BEAS-2B cell line and 
GADD45α is induced in response to many stressors,  we hypothesized that its induction 
may occur through an oxidative stress mechanism.  To assess the role of ROS in 
GADD45α induction, we constructed glutathione peroxidase 1 (GPx1)-EGFP and 
superoxide dismutase 1 (SOD1)-EGFP overexpression/fusion vectors and examined their 
effects on GADD45α protein abundance.  The GPx1 enzyme is a H2O2 scavenger, 
whereas the SOD1 enzyme is a O2˙- scavenger.  GPx1-EGFP, SOD1-EGFP, and empty 
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vector pEGFP-C3 constructs were transiently transfected into BEAS-2B cells.  48 hours 
after transfection, cells were treated with 25 μM As(III) for 12 hours, and subjected to 
Western blot analysis.  Overexpression of the GPx1-EGFP fusion construct reduced 
GADD45α protein abundance by at least 50% (Fig. 3) as measured by densitometry and 
normalized to GAPDH expression (data not shown).  Empty vector and SOD1 construct 
overexpression did not affect GADD45α expression (Fig. 3), implying that the formation 
of H2O2 is partially responsible for the induction of the GADD45α protein in response to 
As(III). 
 
As(III) exposure increases GADD45α  mRNA abundance.  To determine how As(III) 
exposure induces the GADD45α protein, we examined GADD45α transcript abundance 
at several time points using qRT-PCR.  A concentration of 25 μM As(III) was chosen to 
obtain a maximal effect.  Relative quantification of GADD45α mRNA was performed 
using the 0 hour time point as a calibration value.  As shown in Figure 4, GADD45α 
mRNA increases almost 30-fold after three hours of treatment.  Although GADD45α 
mRNA slightly decreased during the following three time points, it began to increase 
again at the 24 hour time point, mimicking the GADD45α protein expression pattern (see 
Fig.1).  Therefore, we reasoned that the gadd45α gene could be transcriptionally induced 
by As(III) exposure.   
 
As(III) activates transcription of gadd45α  through both the promoter region and the 
third intron region.  To establish whether the increase in mRNA abundance resulted 
from transcriptional activation or as a consequence of increased mRNA stability, we 
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examined the effects of As(III) on induction of the gadd45α promoter and intron 3 
regions. GADD45α promoter-luciferase and intron 3-luciferase transcriptional fusion 
constructs were transiently transfected into BEAS-2B cells, subjected to As(III) treatment 
for 12 hours, and assayed for luciferase activity.  The GADD45α promoter construct 
showed a five-fold increase in luciferase activity in response to 25 μM As(III) (Fig. 5).  
Similarly, the GADD45α intron 3 construct exhibited a four-fold increase in activity (Fig. 
5).  Neither of the control constructs containing the luciferase gene alone (GVB2 or GL3) 
showed any discernible difference between the untreated samples and the As(III)-exposed 
samples, illustrating that both the promoter and intron 3 regions of the gadd45a gene are 
activated by As(III) exposure. 
 Since H2O2 was involved in As(III)-induced GADD45a protein levels, we 
examined the effects of H2O2 on the transcriptional activation of gadd45a.  GPx1 or a 
control vector was co-transfected with the aforementioned GADD45α promoter and 
intron 3 constructs.  GPx1 overexpression decreased promoter-luciferase activity by 50% 
when compared to transfection with the empty vector (Fig. 6).  Surprisingly, the control 
vector itself slightly increased luciferase activity in the gadd45a promoter construct.  The 
reason for this phenomenon is unclear.  In contrast, the activity of the intron 3 construct 
after As(III) exposure remained largely unaffected (Fig. 6).  These results suggest a role 
for H2O2 in the transcriptional activation of the gadd45a promoter region. 
 
As(III) activation of  the GADD45α  promoter region occurs between -81 and -234 
relative to the tss.  Given that the GADD45α promoter-luciferase transcriptional fusion 
construct was activated by the presence of H2O2, we wanted to pinpoint which portion of 
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the promoter region was responsible for the activation.  Six GADD45α promoter-
luciferase deletion constructs, named for the length of the promoter region with regards to 
the transcriptional start site (+1), were transfected into BEAS-2B cells and exposed to 25 
μM As(III) for 12 hours (Fig. 7A).  A five- to six- fold increase in luciferase activity was 
observed in all constructs containing at least 234 base pairs upstream of the +1 site (Fig. 
7B).  A further deletion of approximately 150 bp (to -81) eliminated most of the 
luciferase activity.  Putative transcription factor binding sites located in this region 
include consensus sequences for AP-1, MBF-1, Egr-1, Egr-2, Egr-3, and WT1 (-KTS) 
[57]. 
We subsequently examined the effects of As(III)-induced H2O2 formation on the 
induction of the promoter deletion constructs.   Again, GPx1 overexpression and the 
removal of H2O2 decreased luciferase induction by approximately 50% in all constructs 
showing more than five-fold induction (Fig. 7C).  No change was seen in the smaller 
constructs.  These results suggest that the 153 bp region located between -234 and -81 
contains an As(III)-responsive region that is sensitive to the production of H2O2.  
 
Discussion 
The findings presented here suggest that As(III) exposure induces the 
transcriptional activation of the gadd45a gene through a Fenton-like free radical 
mechanism (Fig. 8).  The Fenton reaction, which is usually associated with an excess of 
Fe(II), occurs when a transition metal is oxidized during its interaction with H2O2, 
producing an oxidized metal and two molecules of ˙OH.  Our data show that As(III) 
treatment increases the amount of molecular oxygen consumed by BEAS-2B cells, 
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indicating that more oxygen is available for conversion to O2˙- and subsequent formation 
of H2O2.  In addition, ESR data shows that the relative amount of ˙OH increases in 
response to As(III) exposure, which is alleviated by treatment with the H2O2 scavenger 
enzyme catalase. The removal of H2O2 from the intracellular environment by GPx1 
overexpression decreases gadd45a promoter-luciferase activity and GADD45α protein 
expression, further supporting a role for H2O2 in GADD45α induction. Surprisingly, 
treatment with H2O2 alone only weakly induced GADD45α protein expression when 
compared to equal concentrations of As(III) treatment, whereas co-treatment with H2O2 
and As(III) enhanced GADD45α protein induction (data not shown).  Collectively, these 
results suggest that the formation of ˙OH through a Fenton-like reaction is at least 
partially responsible for the induction of gadd45a transcription and protein expression in 
response to As(III) exposure.   
The induction of gadd45a transcription by the production of H2O2 and/or ˙OH and 
each molecule’s subsequent intracellular activities may partially account for the wide 
variety of chemical and physical inducers of GADD45α protein expression.  IR and UV 
irradiation, both potent inducers of GADD45α expression, also induce ˙OH formation 
[37,58].  Additionally, generation of H2O2 and ˙OH via the Fenton reaction can induce 
the formation of apurinic sites, the same type of DNA lesion induced by another potent 
GADD45α inducer, methyl methanesulfonate (MMS) [37,59].  These data suggest that 
H2O2 and/or ˙OH production may be a key regulator of GADD45α transcriptional 
induction. 
Because, BEAS-2B cells contain a p53 protein that has been inactivated by 
expression of the E6 viral protein, gadd45a transcriptional activation by As(III) occurs 
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through a p53-independent mechanism in these cells [60].  Based on the experimental 
data presented in this manuscript, we have identified several other candidate transcription 
factors that may be involved in gadd45a transcription.  One major candidate is the AP-1 
transcription factor, since it has previously been identified as an As(III)-activated protein 
[61,62].  In addition, the yeast homolog of the human AP-1 protein, Yap1, contains a 
redox regulated domain consisting of  disulfide bonds that can mask or expose its nuclear 
localization sequence, depending on the redox status of the cell [63].  These findings 
make AP-1 an ideal candidate for ROS-mediated transcriptional activation.  Moreover, 
the 153 bp region of the gadd45a promoter-luciferase deletion constructs affected by 
antioxidant overexpression boasts four possible AP-1 consensus binding sequences [57].  
Finally, AP-1 has also been identified as the transcription factor responsible for 
increasing expression of the DNA damage response gene gadd153 after As(III) exposure, 
suggesting that H2O2 production and redox status may be a general mechanism for the 
transcriptional activation of DNA damage response genes [64]. 
Alternatively, the early growth response 1 (Egr-1) transcription factor may also be 
involved in H2O2-mediated transcriptional activation of gadd45a.  Egr-1 has recently 
been shown to induce gadd45a transcription in response to UV irradiation [65].  
Furthermore, Egr-1 induction occurs three hours after 25 μM As(III) treatment 
coincidental with the increase in gadd45a mRNA abundance shown in Fig. 4 (D. Bhatia 
and F. Chen, unpublished data).  Testing is underway in our laboratory to determine the 
effects of Egr-1 on gadd45a transcriptional activation in response to As(III) exposure.   
In conclusion, we have shown that the gadd45a gene is transcriptionally induced 
by As(III) exposure through the formation of H2O2.  This induction occurs in the 
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promoter region of the gadd45a gene and the redox responsive element is located in the -
234 to -81 base pair region.  Future work will focus on the identification of the 
transcription factor(s) responsible for the oxidative stress-dependent transcriptional 
induction of gadd45a.   
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List of Abbreviations: 
GADD45α   growth arrest and DNA damage-inducible protein 45 alpha 
H2O2    hydrogen peroxide 
As(III)    arsenite 
bp    base pairs 
tss    transcriptional start site 
mg    milligram 
μg    microgram 
L    liter 
DNA    deoxyribonucleic acid 
ROS    reactive oxygen species 
NF-κB    nuclear factor κB 
AP-1    activator protein 1  
ERK    extracellular signal-regulated kinase 
G1/S    gap 1/synthesis phase checkpoint 
G2/M    gap2/mitosis phase checkpoint 
MMS    methylmethane sulfonate 
UV    ultraviolet irradiation 
IR    ionizing radiation 
FHRE    forkhead response elements 
mL    milliliter 
AsCl3    arsenic trichloride 
μM    micromolar 
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μL    microliter 
PBS    phosphate buffered saline 
μg    microgram 
PVDF    Polyvinylidene fluoride  
TBS-Tween   Tris-buffered saline 
O2    oxygen 
SEM    standard error of the mean 
mM    millimolar 
ESR    electron spin resonance 
G    Gauss 
DPPH    diphenyl-2-picrylhydrazyl 
K3CrO8    potassium tetraperoxochromate 
GPx1    glutathione peroxidase 1 
SOD1    superoxide dismutase 1 
cDNA    complementary DNA 
EGFP    enhanced green fluorescence protein 
qRT-PCR   quantitative real-time polymerase chain reaction 
RNA    ribonucleic acid 
rRNA    ribosomal ribonucleic acid 
Ct    threshold cycle 
˙OH    hydroxyl radical 
O2˙-     superoxide radical 
GAPDH   Glyceraldehyde-3-phosphate dehydrogenase 
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mRNA    messenger ribonucleic acid 
MBF-1   metal binding factor 1 
Egr-1    early growth response gene 1 
Egr-2    early growth response gene 2 
Egr-3    early growth response gene 3 
Yap1    yeast activator protein 1 
gadd153   growth arrest and DNA damage-inducible protein 153 
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Figure Legends: 
Fig. 1.  25 μM As(III) induces maximal GADD45α  expression at 12 hours. 
A dose/time course Western blot of As(III)-exposed BEAS-2B cells show 
maximal GADD45α induction after 12 hours of treatment. BEAS-2B cells were 
exposed to As(III) concentrations of 0, 3.25, 6.25, 12.5, 25, and 50 μM.  20 μg 
of total protein were loaded into each lane and GADD45α expression was 
detected with a polyclonal antibody. 
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Fig. 2.  A. As(III) exposure increases O2 consumption in BEAS-2B cells. 
 Aliquots of 4 x 106 BEAS-2B cells were injected into a Gilson 5/6 Oxygraph 
and the rate of oxygen consumption was measured with or without a 20 minute exposure 
to 1mM As(III).  O2 consumption in the presence of As(III) was increased approximately 
three fold.   
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Figure 2B. As(III) induces the formation of •OH in BEAS-2B cells.  Formation of  •OH 
was measured by ESR spectroscopy in aliquots of 1 x 106 BEAS-2B cells with or without 
exposure to 1mM As(III).  Figures shown are examples of spectra of control BEAS-2B 
cells (left) and As(III)-exposed BEAS-2B cells (right) exhibiting the characteristic ˙OH 
ESR fingerprint.   
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Figure 2C.  Graphical representation of ESR peak height.  ESR peak heights were 
measured and quantified as described in Materials and Methods.  As(III)-exposed BEAS-
2B cells showed a 2.5 fold increase in the amount of •OH formation which was abrogated 
by the addition of 2000 units/mL of catalase, confirming the identity of •OH. 
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Fig. 3.  Overexpression of the H2O2 scavenging enzyme GPx1 reduces GADD45α 
protein expression. BEAS-2B cells were transiently transfected with a GPx1, SOD1, or 
C3 empty vector and assayed for changes in GADD45α expression via western blot.  




Fig. 4. As(III) exposure increases GADD45α  transcript abundance.  Relative  
qRT-PCR was employed to measure the abundance of the GADD45α transcript using the 
0 hr time point as a calibrator.  Transcript abundance increased approximately 30 fold 
after a three hour As(III) treatment. 
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Fig. 5.  As(III) activates both the GADD45α promoter region and the intron 3 region.  
A dual luciferase reporter system was used to determine the activation of the GADD45α 
promoter-luciferase (G45) and the intron 3-luciferase (Int3) constructs.  Constructs were 
transiently transfected into BEAS-2B cells and luciferase activity was normalized to an 
internal transfection control.  5.2 and 4 fold increases in the G45 and Int3 luciferase 
activity, respectively, were observed in As(III)-exposed samples when compared to the 




Fig. 6.  Overexpression of GPx1 reduces GADD45α  promoter activation, 
but not intron 3 activation.  G45 and Int3 luciferase constructs were transiently 
co-transfected with either an empty vector or the vector overexpressing the GPx1 protein 
and exposed to 25 μM As(III) or left untreated.  GPx1 overexpression decreased the G45 
promoter luciferase activity by 50%, but seemed to have no effect on Int3 activity. 
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Fig. 7A. Schematic diagram of GADD45α promoter-luciferase deletion constructs.  
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Fig. 7B.  GADD45α  promoter activation occurs between the -234 and -81 region. The 
effects of As(III) on the activation of GADD45α promoter luciferase deletion constructs 
were examined after a 12 hour treatment period with 25 μM As(III).  The full length  (-
2552), -1326, -817, and -234 constructs all retained an induction of approximately 5-6 
fold when exposed to arsenic, whereas the -81 construct showed a loss of activation by 
As(III).   
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Fig. 7C.  Activation of the full length, -1326, -817, and -234 constructs was reduced by 
50% in GPx1-overexpressing cell lysates.   
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Fig. 8. Proposed ROS pathway involving arsenic.  The proposed ROS pathway 
responsible for the activation of the gadd45a promoter region is a Fenton-like reaction in 
which molecular oxygen accepts an electron, forming O2˙-, and is then converted to H2O2 
by superoxide dismutase.  H2O2 is then further broken down into water and  molecular 
oxygen, unless the presence of a transition metal, such as As(III), is present.  Excess 
As(III) can then react with H2O2 and produce ˙OH, which leads to DNA damage, lipid 





[1]  Balasoiu, C. F.; Zagury, G. J.; Deschenes, L.  Partitioning and speciation of 
chromium, copper, and arsenic in CCA-contaminated soils:  influence of soil 
composition.  Sci. Total Environ.  280:239-255; 2001. 
[2]  Stephanopoulos, D. E.; Willman, D. A.; Shevlin, D.; Pinter, L.; Gummin, D. D.  
Treatment and toxicokinetics of acute pediatric arsenic ingestion:  danger of arsenic 
insecticides in children.  Pediatr. Crit. Care Med.  3:74-80; 2002. 
[3]  Bailey, E. J.; Kennaway, E. L.; Urquhart, M. E.  Arsenic content of cigarettes.  Br. J. 
Cancer 11:49-53; 1957. 
[4]  Das, H. K.; Mitra, A. K.; Sengupta, P. K.; Hossain, A.; Islam, F.; Rabbani, G. H.  
Arsenic concentrations in rice, vegetables, and fish in Bangladesh: a preliminary study.  
Environ. Int.  30: 383-387; 2004. 
[5]  Haque, R.; Mazumder, D. N.; Samanata, S.; Ghosh, N.; Kalman, D.; Smith, M. M.; 
Mitra, S.; Santra, A.; Lahiri, S.; Das, S.; De, B. K.; Smith, A. H.  Arsenic in drinking 
water and skin lesions:  dose-response data from West Bengal, India.  Epidemiology 
14:174-182; 2003. 
[6]  Roychowdhury, T.; Uchino, T.; Tokunaga, H.; Ando, M.  Arsenic and other heavy 
metals in soils from an arsenic-affected area of West Bengal, India.  Chemosphere 
49:605-618; 2002. 
[7]  Axelson, O.; Dahlgren, E.; Jansson, C. D.; Rehnlund, S. O.  Arsenic exposure and 
mortality:  a case-referent study from a Swedish copper smelter.  Br. J. Ind. Med 35:8-15; 
1978. 
 168
[8]  Smith, A. H.; Lingas, E. O.; Rahman, M.  Contamination of drinking-water by 
arsenic in Bangladesh:  a public health emergency.  Bull. World Health Organ.  78:1093-
1103;  2000. 
[9]  Centeno, J. A.; Mullick, F. G.; Martinez, L.; Page, N. P.; Gibb, H.; Longfellow, D.; 
Thompson, C.; Ladich, E. R.  Pathology related to chronic arsenic exposure.  Environ. 
Health Perspect.  110 Supp 5: 883-886; 2002. 
[10]  Chen, C. J.; Chuang, Y. C.; Lin, T. M.; Wu, H. Y.  Malignant neoplasms among 
residents of a blackfoot disease-endemic area in Taiwan:  high-arsenic artesian well water 
and cancers.  Cancer Res.  45:5895-5899; 1985. 
[11]  Chen, C. J.; Hsueh, Y. M.; Lai, M. S.; Shyu, M. P.; Chen, S. Y.; Wu, M. M.; Kuo, 
T. L.; Tai, T. Y.  Increased prevalence of hypertension and long-term arsenic exposure.  
Hypertension  25:53-60; 1995. 
[12]  International Agency for Research on Cancer (IARC).  Carcinogenesis of arsenic 
compounds.  IARC Monograph on Evaluation of Carcinogenic Risks  23:37-141; 1980.   
[13]  Leonard, A.; Lauwerys, R. R.  Carcinogenicity, teratogenicity, and mutagenicity of 
arsenic.  Mutat. Res.  75:49-62; 1980. 
[14]  Mabuchi, K.; Lilienfeld, A. M.; Snell, L. M.  Lung cancer among pesticide workers 
exposed to inorganic arsenicals.  Arch. Environ. Health  34:312-320; 1979. 
[15]  Pinto, S. S.; Nelson, K. W.  Arsenic toxicology and industrial exposure.  Annu. Rev. 
Pharmacol. Toxicol.  16:95-100; 1976. 
[16]  Pinto, S. S.; Enterline, P. E.; Henderson, V.; Varner, M. O.  Mortality experience in 
relation to a measured arsenic trioxide exposure.  Environ. Health Perspect.  19:127-130; 
1977. 
 169
[17]  Steinmaus, C.; Moore, L.; Hopenhayn-Rich, C.; Biggs, M. L.; Smith, A. H.  Arsenic 
in drinking water and bladder cancer.  Cancer Invest.  18:174-182; 2000. 
[18]  World Health Organization (WHO).  Arsenic in Drinking Water.  Fact Sheet No. 
210  Geneva:  WHO Press; 2001. 
[19]  National Research Council (NRC).  Arsenic in Drinking Water.  Washington, D.C.:  
National Academy Press; 1999. 
[20]  Klaassen, C. D.; Amdur, M. O.; Doull, J.  Cassarett and Doull’s Toxicology:  The 
Basic Sciences of Poisons.  New York: McGraw-Hill; 1996. 
[21]  Bagla, P.; Kaiser, J.  India’s spreading health crisis draws global arsenic experts.  
Science  274: 174-175; 1996. 
[22]  Lewis, D. R.; Southwick, J. W.; Ouellet-Hellstrom, R.; Rench, J.; Calderon, R. L.  
Drinking water arsenic in Utah:  A cohort mortality study.  Environ. Health Perspect. 
107: 359-365; 1999. 
[23] Nordstrom, D. K. Public health.  Worldwide occurrences of arsenic in ground water.  
Science  296: 2143-2145; 2002. 
[24]  Natural Resources Defense Council (NRDC).  Arsenic and old laws: a scientific and 
public health analysis of arsenic occurrence in drinking water, its health effects, and 
EPA’s outdated arsenic tap water standard.  
http://www.nrdc.org/water/drinking/arsenic/chap1.asp
[25]  Rossman, T. G.; Stone, D.; Molina, M.; Troll, W.  Absence of arsenite mutagenicity 
in E. coli and Chinese hamster cells.  Environ. Mutagen. 2: 371-379; 1980. 
[26]  Germolec, D. R.; Spalding, J.; Boorman, G. A.; Wilmer, J. L.; Yoshida, T.; 
Simeonova, P. P.; Bruccoleri, A.; Kayama, F.; Gaido, K.; Tennant, R.; Burleson, F.; 
 170
Dong, W.; Lang, R. W.; Luster, M. I.  Arsenic can mediate skin neoplasia by chronic 
stimulation of keratinocyte-derived growth factors.  Mutat. Res.  386: 209-218; 1997. 
[27]  Germolec, D. R.; Spalding, J.; Yu, H.S.; Chen, G. S.; Simeonova, P. P.; Humble, M. 
C.; Bruccoleri, A.; Boorman, G. A.; Foley, J. F.; Yoshida, T.; Luster, M. I.  Arsenic 
enhancement of skin neoplasia by chronic stimulation of growth factors.  Am. J. Pathol.  
153: 1775-1785; 1998. 
[28]  Kachinskas, D. J.; Philips, M. A.; Qin, Q.; Stokes, J. D.; Rice, R. H.  Arsenate 
perturbation of human keratinocyte differentiation..  Cell Growth Diff.  5: 1235-1241; 
1994. 
[29]  Huang, C.; Ma, W. Y.; Li, J.; Goranson, A.; Dong, Z.  Requirement of Erk, but not 
JNK, for arsenite-induced cell transformation.  J. Biol. Chem.  274: 14595-14601; 1999. 
[30]  Chen, F.; Zhang, Z.; Leonard, S. S.; Shi, X.  Contrasting roles of NF-kappaB and 
JNK in arsenite-induced p53-independent expression of GADD45alpha.  Oncogene  20: 
3585-3589; 2001. 
[31]  Wijeweera, J. B.; Gandolfi, A. J.; Parrish, A.; Lantz, R. C.  Sodium arsenite 
enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in 
precision-cut rat lung slices.  Toxicol. Sci.  61: 283-294; 2001. 
[32]  Chen, F.; Lu, Y.; Zhang, Z.; Vallyathan, V.; Ding, M.; Castranova, V.; Shi, X.  
Opposite effect of NF-kappaB and c-Jun N-terminal kinase on p53-independent 
GADD45 induction by arsenite.  J. Biol. Chem.  276: 11414-11419; 2001. 
[33]  Yih, L.H., Hsueh, S.W., Luu, W.S., Chiu, T.H., Lee, T.C.  Arsenite induces 
prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells.  
Carcinogenesis 26: 53-63; 2005. 
 171
[34]  Chen, F., Zhang, Z., Bower, J., Lu, Y., Leonard, S.S., Ding, M., Castranova, V., 
Piwinica-Worms, H., Shi, X.  Arsenite-induced Cdc25C degradation is through the KEN-
box and ubiquitin-proteosome pathway.  Proc. Natl. Acad. Sci. U.S.A. 99: 1990-1995; 
2002. 
[35]  Park, W.H., Seol, J.G., Kim, E.S., Hyun, J.M., Jung, C.W., Lee, C.C., Kim, B.K., 
Lee, Y.Y.  Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via 
cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, 
and apoptosis.  Cancer Res. 60: 3065-3071; 2000. 
[36]  Seol, J.G., Park, W.H., Kim, E.S., Jung, C.W., Hyun, J.M., Kim, B.K., Lee, Y.Y.  
Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.  
Biochm. Biophys. Res. Commun.  265; 400-404. 
[37]  Fornace, A. J. Jr.; Nebert, D. W.; Hollander, M. C.; Luethy, J. D.; Papathanasiou, 
M.; Fargnoli, J.; Holbrook, N. J.  Mammalian genes coordinately regulated by growth 
arrest signals and DNA-damaging agents.  Mol. Cell. Biol.  9: 4196-4203; 1989. 
[38]  Yih, L. H.; Peck, K.; Lee, T. C.  Changes in gene expression profiles of human 
fibroblasts in response to sodium arsenite treatment.  Carcinogenesis  23: 867-876; 2002. 
[39]  Andrew, A. S.; Warren, A. J.; Barchowsky, A.; Temple, K. A.; Klei, L.; Soucy, N. 
V.; O’Hara, K. A.; Hamilton, J. W.  Genomic and proteomic profiling of responses to 
toxic metals in human lung cells.  Environ. Health Perspect.  111: 825-835; 2003. 
[40]  Zhan, Q.; Antinore, M. J.; Wang, X. W.; Carrier, F.; Smith, M. L.; Harris, C. C.; 
Fornace, A. J. Jr.  Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase 
activity by the p53-regulated protein Gadd45.  Oncogene  18: 2892-2900; 1999. 
 172
[41]  Wang, X. W.; Zhan, Q.; Coursen, J. D.; Khan, M. A.; Kontny, H. U.; Yu, L.; 
Hollander, M. C.; O’Conner, P. M.; Fornace, A. J. Jr.; Harris, C. C.  GADD45 induction 
of a G2/M cell cycle checkpoint.  Proc. Natl. Acad. Sci. U. S. A.  96: 3706-3711; 1999. 
[42]  Mak, S. K.; Kultz, D.  Gadd45 proteins induce G2/M arrest and modulate apoptosis 
in kidney cells exposed to hyperosmotic stress.  J. Biol. Chem.  279: 39075-39084; 2004. 
[43]  Carrier, F.; Georgel, P. T.; Pourquier, P.; Blake, M.; Kontny, H. U.; Antinore, M. J.; 
Gariboldi, M.; Myers, T. G.; Weinstein, J. N.; Pommier, Y.; Fornace, A. J. Jr.  Gadd45, a 
p53-responsive stress protein, modifies DNA accessibility on damaged chromatin.  Mol. 
Cell. Biol.  19: 1673-1685; 1999. 
[44]  Kastan, M. B.; Zhan, Q.; el-Deiry, W. S.; Carrier, F.; Jacks, T.; Walsh, W. V.; 
Plunkett, B. S.; Vogelstein, B.; Fornace, A. J. Jr.  A mammalian cell cycle checkpoint 
pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.  Cell  71: 587-
597; 1992.  
[45]  Graunke, D. M.; Fornace, A. J. Jr.; Pieper, R. O.  Presetting of chromatin structure 
and transcription factor binding poise the human GADD45 gene for rapid transcriptional 
up-regulation.  Nucleic Acids Res.  27: 3881-3890; 1999. 
[46]  Zhan, Q.; Chen, I. T.; Antinore, M. J.; Fornace, A. J. Jr.  Tumor suppressor p53 can 
participate in transcriptional induction of the GADD45 promoter in the absence of direct 
DNA binding.  Mol. Cell. Biol.  18: 2768-2778; 1998. 
[47]  Takahashi, S.; Satio, S.; Ohtani, N.; Sakai, T.  Involvement of the Oct-1 regulatory 
element of the gadd45 promoter in the p53-independent response to ultraviolet 
irradiation.  Cancer Res.  61: 1187-1195; 2001. 
 173
[48]  Jin, S.; Fan, F.; Fan, W.; Zhao, H.; Tong, T.; Blanck, P.; Alomo, I.; Rajasekaran, B.; 
Zhan, Q.  Transcription factors Oct-1 and NF-YA regulate the p53-independent induction 
of the GADD45 following DNA damage.  Oncogene  20: 2683-2690; 2001. 
[49]  Zhao, H.; Jin, S.; Fan, F.; Fan, W.; Tong, T.; Zhan, Q.  Activation of the 
transcription factor Oct-1 in response to DNA damage.  Cancer Res  60: 6276-6280; 
2000. 
[50]  Daino, K.; Ichimura, S.; Nenoi, M.  Comprehensive search for x-ray-responsive 
elements and binding factors in the regulatory region of the GADD45a gene.  J. Radiat. 
Res. (Tokyo).  44: 311-318; 2003. 
[51]  Tran, H.; Brunet, A.; Grenier, J. M.; Datta, S. R.; Fornace, A. J. Jr.; DiStefano, P. 
S.; Chiang, L. W.; Greenberg, M. E.  DNA repair pathway stimulated by the forkhead 
transcription factor FOXO3a through the GADD45 protein.  Science  296: 530-534; 
2002. 
[52]  Li, S.; Yan, T.; Yang, J. Q.; Oberley, T. D.; Oberley, L. W.  The role of cellular 
glutathione peroxidase redox regulation in the suppression of tumor cell growth by 
manganese superoxide dismutase.  Cancer Res.  60: 3927-3939; 2000. 
[53]  Zhang, Y.; Zhao, W.; Zhang, H. J.; Domann, F. E.; Oberley, L. W.  Overexpression 
of copper zinc superoxide dismutase suppresses human glioma cell growth.  Cancer Res.  
62: 1205-1212; 2002. 
[54]  Bruemmer, D., Yin, F., Liu, J., Berger, J.P., Sakai, T., Blaschke, F., Fleck, E., Van 
Herle, A.J., Forman, B.M., Law, R.E.  Regulation of the growth arrest and DNA damage-
inducible gene 45 (GADD45) by peroxisome proliferators-activated receptor gamma in 
vascular smooth muscle cells.  Circ. Res. 93: e38-47; 2003. 
 174
[55]  Zhan, Q., Chen, I.T., Antinore, M.J., Fornace, A.J. Jr.  Tumor suppressor p53 can 
participate in transcriptional induction of the GADD45 promoter in the absence of direct 
DNA binding.  Mol. Cell. Biol. 18; 2768-2778; 1998. 
[56]  Hei, T. K.; Liu, S. X.; Waldren, C.  Mutagenicity of arsenic in mammalian cells: 
role of reactive oxygen species.  Proc. Natl. Acad. Sci. U. S. A.  95: 8103-8107; 1998. 
[57]  Schug, J.; Overton, G. C.  TESS: Transcription Element Search Software on the 
WWW'.  Technical Report CBIL-TR-1997-1001-v0.0.  Computational Biology and 
Informatics Laboratory, School of Medicine, University of Pennsylvania; 1997. 
http://www.cbil.upenn.edu/tess
[58]  Halliwell, B.; Gutteridge, J. M. C.  Free Radicals in Biology and Medicine.  New 
York:  Oxford University Press, Inc.; 1999. 
[59]  Nakamura, J., La, D.K., Swenberg, J.A.  5’-nicked apurinic/apyrimidinic sites are 
resistant to β-elimination by β-polymerase and are persistent in human cultured cells after 
oxidative stress.  J. Biol. Chem. 275: 5323-5328; 2000. 
[60]  Reddel, R.R., Ke, Y., Gerwin, B.I., McMenamin, M.G., Lechner, J.F., Su, R.T., 
Brash, D.E., Park, J.B., Rhim, J.S., Harris, C.C.  Transformation of human bronchial 
epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or 
transfection via strontium phosphate coprecipitation with a plasmid containing SV40 
early region genes.  Cancer Res.  48: 1904-1909; 1988. 
[61]  Cavigelli, M.; Li, W. W.; Lin, A.; Su, B.; Yoshioka, K.; Karin, M.  The tumor 
promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.  EMBO J.  
15: 6269-6279; 1996. 
[62]  Simeonova, P. P.; Wang, S.; Toriuma, W.; Kommineni, V.; Matheson, J.; Unimye, 
N.; Kayama, F.; Harki, D.; Ding, M.; Vallyathan, V.; Luster, M. I.  Arsenic mediates cell 
 175
proliferation and gene expression in the bladder epithelium: association with activating 
protein-1 transactivation.  Cancer Res.  60: 3445-3453; 2000. 
[63]  Wood, M. J.; Storz, G.; Tjandra, N.  Structural basis for redox regulation of Yap1 
transcription factor localization.  Nature  430: 917-921 ; 2004. 
[64]  Guyton, K. Z.; Xu, Q.; Holbrook, N. J.  Induction of the mammalian stress response 
gene GADD153 by oxidative stress: role of AP-1 element.  Biochem. J.  314: 547-554; 
1996.  
[65]  Thyss, R., Virolle, V., Imbert, V., Peyron, J.F., Aberdam, D., Virolle, T.  NF-
κB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal 





1. Gene-environment interactions are an integral part of environmental-induced 
carcinogenesis.  The elucidation of the human genome sequence and new 
techniques that have emerged will play a major role in understanding the 




2. Metal exposure is a major contributor to environmental induced carcinogenesis.  
Each metal produces its own effects, and these effects are different for each cell 
type.  Identification of each individual mechanism of metal-induced 
carcinogenesis is necessary in order to obtain effective treatments. 
 
 
3. Arsenite produces hydroxyl radical in the BEAS-2B cell line. 
 
 
4. Arsenite induces GADD45α in a dose- and time-dependent manner. 
 
 
5. Arsenite can eleveate hydrogen peroxide and/or hydroxyl radical production and 
subsequently GADD45α protein levels in the BEAS-2B cell line. 
 
 
6. Arsenite induces hydrogen peroxide-mediated GADD45α transcription. 
 
 
7. A 153 base pair region of the GADD45 promoter is regulated by As(III)-
induced hydrogen peroxide formation. 
 
 
8. Arsenite induces GADD45α expression in a p53-independent manner in the 
BEAS-2B cell line. 
 
 
9. The transcriptional induction of the gadd45a gene by arsenite seems to occur 
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